<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">NdH7WGqLVzMM6fC6vJ7yMNk</article-id>
      <article-id pub-id-type="other">00014</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2010001400014</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(10)09500414</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2010005000126</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Efeito do exerc&#237;cio f&#237;sico e do polimorfismo T-786C na press&#227;o arterial e no fluxo sangu&#237;neo de idosas</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Zago</surname>
            <given-names>Anderson Saranz</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kokubun</surname>
            <given-names>Eduardo</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fenty-Stewart</surname>
            <given-names>Nicola</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Joon-Young</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Attipoe</surname>
            <given-names>Selasi</given-names>
          </name>
          <xref ref-type="aff" rid="aff04"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hagberg</surname>
            <given-names>James</given-names>
          </name>
          <xref ref-type="aff" rid="aff04"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brown</surname>
            <given-names>Michael</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
      </contrib-group>
      <aff id="aff04">
        <addr-line>
          <named-content content-type="city">College Park</named-content>
          <named-content content-type="state"/>
        </addr-line>
        <institution content-type="orgname">University of Maryland</institution>
        <institution content-type="orgdiv1">Department of Kinesiology </institution>
        <country country="US">United States</country>
      </aff>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Ribeir&#227;o Preto</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Escola de Educa&#231;&#227;o F&#237;sica e Esportes </institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">Rio Claro</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Estadual Paulista</institution>
        <institution content-type="orgdiv1">Departamento de Educa&#231;&#227;o F&#237;sica </institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff03">
        <addr-line>
          <named-content content-type="city">Philadelphia</named-content>
          <named-content content-type="state"/>
        </addr-line>
        <institution content-type="orgname">Temple University</institution>
        <institution content-type="orgdiv1">Department of Kinesiology </institution>
        <country country="US">United States</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>10</month>
        <year>2010</year>
      </pub-date>
      <volume>95</volume>
      <issue>4</issue>
      <fpage>510</fpage>
      <lpage>518</lpage>
      <history>
        <date date-type="rev-recd">
          <day>26</day>
          <month>01</month>
          <year>2010</year>
        </date>
        <date date-type="received">
          <day>18</day>
          <month>05</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>04</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: O polimorfismo T-786C do gene da sintetase do &#243;xido n&#237;trico endotelial (eNOS) e a produ&#231;&#227;o de &#226;nion super&#243;xido podem diminuir a produ&#231;&#227;o e biodisponibilidade do &#243;xido n&#237;trico, comprometendo o grau de vasodilata&#231;&#227;o, podendo este efeito ser revertido pelo exerc&#237;cio f&#237;sico. OBJETIVO: Investigar a influ&#234;ncia do treinamento aer&#243;bico e do polimorfismo T-786C nas concentra&#231;&#245;es dos metab&#243;litos do &#243;xido n&#237;trico (NOx), no fluxo sangu&#237;neo (FS) e na press&#227;o arterial (PA). M&#201;TODOS: Trinta e duas idosas pr&#233;-hipertensas (59 &#177; 6 anos) foram separadas em dois grupos de acordo com o polimorfismo T-786C (TT e TC+CC). Foram analisadas as concentra&#231;&#245;es de NOx (plasma) e fluxo sangu&#237;neo por pletismografia de oclus&#227;o venosa em repouso, 1, 2 e 3 minutos p&#243;s-oclus&#227;o (FS-0, FS-1, FS-2, FS-3, respectivamente). As avalia&#231;&#245;es foram realizadas antes e ap&#243;s 6 meses de um programa de exerc&#237;cio aer&#243;bico. RESULTADOS: Nas avalia&#231;&#245;es pr&#233;-treinamento, os n&#237;veis de NOx foram menores no grupo TC+CC em rela&#231;&#227;o ao grupo TT. O grupo TT apresentou correla&#231;&#245;es entre NOx e FS-0 (r = 0,6) e press&#227;o arterial diast&#243;lica (PAD) e FS-0 (r = -0,7), por&#233;m nenhuma correla&#231;&#227;o foi encontrada no grupo TC+CC. Nas avalia&#231;&#245;es p&#243;s-treinamento, ocorreram correla&#231;&#245;es entre NOx e FS-0 (r = 0,6) e nas mudan&#231;as do NOx e PAD (r = -0,6) no grupo TT. Tamb&#233;m foram obtidas correla&#231;&#245;es entre PAD e FS-1 (r = -0,8), PAD e FS-2 (r = -0,6), PAD e FS-3 (r = -0,6), nas mudan&#231;as entre NOx e FS-1 (r = 0,8) e mudan&#231;as do NOx e PAD (r = -0,7) no grupo TC+CC. CONCLUS&#195;O: Conclui-se que 6 meses de exerc&#237;cio aer&#243;bico podem contribuir para aumentar as rela&#231;&#245;es existentes entre NO, PA e FS em idosas portadores do alelo C.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>&#211;xido n&#237;trico</kwd>
        <kwd>super&#243;xido dismutase</kwd>
        <kwd>exerc&#237;cio</kwd>
        <kwd>press&#227;o arterial</kwd>
        <kwd>idoso</kwd>
        <kwd>polimorfismo gen&#233;tico</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>17</day>
        <month>09</month>
        <year>2010</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>ARTIGO ORIGINAL </p>
    <p> HIPERTENS&#195;O ARTERIAL SIST&#202;MICA </p>
    <p>
      <bold>Efeito do exerc&#237;cio f&#237;sico e do polimorfismo T-786C na press&#227;o arterial e no fluxo sangu&#237;neo de idosas</bold>
    </p>
    <p>
      <bold>Anderson Saranz Zago<sup>I</sup>; Eduardo Kokubun<sup>II</sup>; Nicola Fenty-Stewart<sup>III</sup>; Joon-Young Park<sup>III</sup>; Selasi Attipoe<sup>IV</sup>; James Hagberg<sup>IV</sup>; Michael Brown<sup>III</sup></bold>
    </p>
    <p><sup>I</sup>Escola de Educa&#231;&#227;o F&#237;sica e Esportes - USP, Ribeir&#227;o Preto, SP - Brasil </p>
    <p><sup>II</sup>Departamento de Educa&#231;&#227;o F&#237;sica - UNESP, Rio Claro, SP - Brasil </p>
    <p><sup>III</sup>Department of Kinesiology - Temple University, Philadelphia - USA </p>
    <p><sup>IV</sup>Department of Kinesiology - University of Maryland, College Park - USA</p>
    <p>
      <xref ref-type="corresp" rid="back">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO: </bold> O polimorfismo T-786C do gene da sintetase do &#243;xido n&#237;trico endotelial (eNOS) e a produ&#231;&#227;o de &#226;nion super&#243;xido podem diminuir a produ&#231;&#227;o e biodisponibilidade do &#243;xido n&#237;trico, comprometendo o grau de vasodilata&#231;&#227;o, podendo este efeito ser revertido pelo exerc&#237;cio f&#237;sico. </p>
    <p><bold>OBJETIVO: </bold> Investigar a influ&#234;ncia do treinamento aer&#243;bico e do polimorfismo T-786C nas concentra&#231;&#245;es dos metab&#243;litos do &#243;xido n&#237;trico (NOx), no fluxo sangu&#237;neo (FS) e na press&#227;o arterial (PA). </p>
    <p><bold>M&#201;TODOS: </bold> Trinta e duas idosas pr&#233;-hipertensas (59 &#177; 6 anos) foram separadas em dois grupos de acordo com o polimorfismo T-786C (TT e TC+CC). Foram analisadas as concentra&#231;&#245;es de NOx (plasma) e fluxo sangu&#237;neo por pletismografia de oclus&#227;o venosa em repouso, 1, 2 e 3 minutos p&#243;s-oclus&#227;o (FS-0, FS-1, FS-2, FS-3, respectivamente). As avalia&#231;&#245;es foram realizadas antes e ap&#243;s 6 meses de um programa de exerc&#237;cio aer&#243;bico. </p>
    <p><bold>RESULTADOS: </bold> Nas avalia&#231;&#245;es pr&#233;-treinamento, os n&#237;veis de NOx foram menores no grupo TC+CC em rela&#231;&#227;o ao grupo TT. O grupo TT apresentou correla&#231;&#245;es entre NOx e FS-0 (r = 0,6) e press&#227;o arterial diast&#243;lica (PAD) e FS-0 (r = -0,7), por&#233;m nenhuma correla&#231;&#227;o foi encontrada no grupo TC+CC. Nas avalia&#231;&#245;es p&#243;s-treinamento, ocorreram correla&#231;&#245;es entre NOx e FS-0 (r = 0,6) e nas mudan&#231;as do NOx e PAD (r = -0,6) no grupo TT. Tamb&#233;m foram obtidas correla&#231;&#245;es entre PAD e FS-1 (r = -0,8), PAD e FS-2 (r = -0,6), PAD e FS-3 (r = -0,6), nas mudan&#231;as entre NOx e FS-1 (r = 0,8) e mudan&#231;as do NOx e PAD (r = -0,7) no grupo TC+CC. </p>
    <p><bold>CONCLUS&#195;O:</bold> Conclui-se que 6 meses de exerc&#237;cio aer&#243;bico podem contribuir para aumentar as rela&#231;&#245;es existentes entre NO, PA e FS em idosas portadores do alelo C.</p>
    <p><bold>Palavras-chave: </bold> &#211;xido n&#237;trico, super&#243;xido dismutase, exerc&#237;cio, press&#227;o arterial, idoso, polimorfismo gen&#233;tico.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>O &#243;xido n&#237;trico (NO) produzido pela sintetase do &#243;xido n&#237;trico endotelial (eNOS) possui uma importante fun&#231;&#227;o no controle cardiovascular, especialmente para a vasodilata&#231;&#227;o<sup>1,2</sup>. Quando a eNOS &#233; ativada, o metabolismo da L-arginina &#233; aumentado gerando a forma&#231;&#227;o de L-citrulina e de NO pelas c&#233;lulas endoteliais<sup>3-5</sup>. Uma vez produzido, o NO migra para a c&#233;lula muscular lisa vascular gerando um aumento da atividade da guanilato ciclase, culminando na diminui&#231;&#227;o de c&#225;lcio e no relaxamento da musculatura lisa vascular<sup>5,6</sup>.</p>
    <p>No vaso sangu&#237;neo, dentre os mecanismos envolvidos na manuten&#231;&#227;o das concentra&#231;&#245;es adequadas de NO, podem-se destacar a atividade da eNOS e a biodisponibilidade de NO<sup>7-12</sup>.</p>
    <p>A atividade da eNOS pode ser geneticamente determinada e alguns polimorfismos t&#234;m sido identificados como potenciais candidatos para o desenvolvimento da hipertens&#227;o arterial<sup>9</sup>. Por exemplo, o alelo C do polimorfismo T-786C da regi&#227;o promotora do gene da eNOS tem sido capaz de diminuir a atividade promotora e transcripcional desse gene, reduzindo a produ&#231;&#227;o de NO<sup>7,13</sup>.</p>
    <p>A biodisponibilidade de NO est&#225; estreitamente relacionada com a produ&#231;&#227;o de &#226;nion super&#243;xido (O<sub>2</sub><sup>-</sup>) produzido pelo endot&#233;lio, camada advent&#237;cia e c&#233;lula muscular lisa vascular<sup>1,14-18</sup><sub>.</sub> Tanto fatores f&#237;sicos quanto humorais, como por exemplo o <italic>shear stress,</italic> podem modular a atividade da NAD(P)H oxidase e induzir a produ&#231;&#227;o de O<sub>2</sub><sup>- 12,19</sup>. O aumento de O<sub>2</sub><sup>-</sup> no sistema cardiovascular pode gerar uma disfun&#231;&#227;o endotelial e um aumento da contratilidade vascular<sup>2,12</sup>. Quando produzido em excesso, os O<sub>2</sub><sup>-</sup> reagem com o NO produzindo peroxinitrite (ONOO<sup>-</sup>), diminuindo a biodisponibilidade do NO<sup>2</sup>.</p>
    <p>Contrapondo-se aos efeitos de ambos os mecanismos (polimorfismos do gene da eNOS e da produ&#231;&#227;o de O<sub>2</sub><sup>-</sup>), o exerc&#237;cio aer&#243;bico tem sido apontado como um dos principais est&#237;mulos para combater tais disfun&#231;&#245;es endoteliais<sup>2,19,20</sup>. O <italic>shear stress</italic> induzido pelo aumento do fluxo sangu&#237;neo, especialmente durante a realiza&#231;&#227;o de exerc&#237;cios f&#237;sicos, pode beneficiar o mecanismo de controle cardiovascular em praticamente dois mecanismos. Primeiro, pelo aumento da express&#227;o da eNOS e, consequentemente, da produ&#231;&#227;o de NO, e segundo, pela produ&#231;&#227;o da enzima super&#243;xido dismutase extracelular (ecSOD), que possui a capacidade de reagir com os O<sub>2</sub><sup>-</sup>; aumentando potencialmente a disponibilidade de NO para a c&#233;lula muscular lisa vascular<sup>11,20</sup>.</p>
    <p>De tal forma, o exerc&#237;cio f&#237;sico pode regular a vasodilata&#231;&#227;o mediada pelo NO diminuindo os valores de press&#227;o arterial na maioria dos indiv&#237;duos hipertensos<sup>2</sup>. Contudo, ainda existem controv&#233;rsias entre os estudos com rela&#231;&#227;o aos efeitos ben&#233;ficos do exerc&#237;cio f&#237;sico no aumento das concentra&#231;&#245;es de NO e na resposta vasodilatadora em indiv&#237;duos portadores do polimorfismo do gene da eNOS<sup>11</sup>.</p>
    <p>Assim, o objetivo deste estudo foi investigar a influ&#234;ncia que o exerc&#237;cio f&#237;sico regular e o polimorfismo T-786C do gene da eNOS teriam nos n&#237;veis circulantes dos metab&#243;litos do NO (NOx), na atividade da ecSOD, no fluxo sangu&#237;neo (FS) e na press&#227;o arterial (PA) de mulheres idosas pr&#233;-hipertensas.</p>
    <p>
      <bold>Materiais e m&#233;todos</bold>
    </p>
    <p>
      <bold>Participantes</bold>
    </p>
    <p>Este estudo foi aprovado pelo Comit&#234; de &#201;tica da <italic>University of Maryland College Park</italic>/<italic>USA</italic> e pelo Comit&#234; de &#201;tica em Pesquisa do Instituto de Bioci&#234;ncias/CEP-IB-UNESP.</p>
    <p>Em sua primeira visita ao laborat&#243;rio, todos os participantes assinaram um termo de consentimento livre e esclarecido. Participaram 32 mulheres aparentemente saud&#225;veis, entre 50-70 anos, sedent&#225;rias, pr&#233;-hipertensas (sem uso de medica&#231;&#227;o), n&#227;o diab&#233;tica e n&#227;o fumante. As mulheres com sobrepeso e obesidade (IMC &gt; 37 kg/m<sup>2</sup>) foram eliminadas do estudo para se evitar a interfer&#234;ncia destas vari&#225;veis nos resultados deste estudo.</p>
    <p>As participantes foram divididas em dois grupos conforme o resultado da an&#225;lise do polimorfismo do gene da eNOS, sendo classificadas como TT e TC+CC. As mulheres no per&#237;odo de p&#243;s-menopausa (83,0% do total das participantes), que faziam uso de terapia de reposi&#231;&#227;o hormonal (45,0% das participantes), mantiveram as medica&#231;&#245;es durante o estudo.</p>
    <p>
      <bold>Procedimentos</bold>
    </p>
    <p>Todos os participantes realizaram o teste de Bruce em esteira com eletrocardiograma para a detec&#231;&#227;o de doen&#231;a cardiovascular, conforme descrito previamente<sup>21</sup>. Um registro de dieta foi realizado e os participantes foram instru&#237;dos a manter a fase 1 da dieta do <italic>American Heart Association (AHA)</italic>, com estabilidade do peso a pelo menos 3 semanas, conforme descrito previamente<sup>22</sup>. Todos os testes b&#225;sicos foram realizados antes e ap&#243;s 6 meses de um programa de treinamento f&#237;sico e a diferen&#231;a entre as avalia&#231;&#245;es pr&#233; e p&#243;s (p&#243;s - pr&#233; = diferen&#231;a) tamb&#233;m foi utilizada para fins de verificar a efic&#225;cia do treinamento em cada vari&#225;vel estudada.</p>
    <p>
      <bold>Testes b&#225;sicos</bold>
    </p>
    <p>As avalia&#231;&#245;es compreenderam os testes de consumo m&#225;ximo de oxig&#234;nio (VO<sub>2</sub>max), fluxo sangu&#237;neo (FS), press&#227;o arterial (PA) e coleta sangu&#237;nea.</p>
    <p><italic>Consumo m&#225;ximo de oxig&#234;nio (VO<sub>2</sub>max)</italic> - O VO<sub>2</sub>max foi determinado pelo teste de exaust&#227;o volunt&#225;ria, atrav&#233;s de um sistema de calorimetria indireta (modelo 2300, Hans Rudolph, Inc., Kansas City, Missouri) e analisador de gases (modelo 1100, Perkin Elmer, Inc., Danbury, Connecticut) conectados a um computador. O VO<sub>2</sub>max foi determinado quando dois dos tr&#234;s crit&#233;rios fossem alcan&#231;ados: troca respirat&#243;ria <italic>&gt;</italic> 1,1; Frequ&#234;ncia card&#237;aca &gt; 220 - idade; e um aumento maior do que 150 ml min<sup>"1</sup> no VO<sub>2,</sub> durante os dois &#250;ltimos minutos de teste<sup>23</sup>. Durante o teste, a frequ&#234;ncia card&#237;aca (FC), PA e o eletrocardiograma foram monitorados.</p>
    <p><italic>Fluxo sangu&#237;neo</italic><bold>-</bold> Todos os participantes foram conduzidos ao laborat&#243;rio entre as 07:00 e 9:00 horas ap&#243;s um jejum de 12 horas. Os participantes permaneceram em repouso, na posi&#231;&#227;o deitada por 15 minutos, e o fluxo sangu&#237;neo foi medido no antebra&#231;o n&#227;o dominante usando-se a t&#233;cnica de pletismografia de oclus&#227;o venosa. Resumidamente, usando um inflador autom&#225;tico, um pequeno manguito foi inflado ao redor do punho e um manguito maior ao redor do bra&#231;o (&#250;mero) a 180 mmHg e 55 mmHg, respectivamente. Para criar a isquemia do bra&#231;o, o manguito foi inflado a 50 mmHg acima da press&#227;o arterial sist&#243;lica de repouso, sendo mantida por 5 minutos. Ap&#243;s esse per&#237;odo de isquemia, o manguito do punho foi inflado novamente e o do bra&#231;o foi inflado a 55 mmHg, a cada minuto<sup>24</sup>. Tem sido mostrado que o tecido possui a capacidade de se recuperar da isquemia em tr&#234;s minutos e que o pico de vasodilata&#231;&#227;o ocorre em aproximadamente um minuto ap&#243;s a libera&#231;&#227;o do manguito<sup>24,25</sup>. Assim, o FS foi medido no repouso (FS-0) e um, dois e tr&#234;s minutos de hiperemia reativa (FS-1, FS-2 e FS-3, respectivamente), ap&#243;s os 5 minutos de isquemia. A FC e a PA foram medidas simultaneamente no outro bra&#231;o. A resist&#234;ncia vascular (RV) do bra&#231;o foi calculada com a m&#233;dia da PA dividida pelo FS.</p>
    <p><italic>Press&#227;o arterial casual</italic><bold>-</bold> As PA sist&#243;lica e PA diast&#243;lica (PAS e PAD) foram medidas ap&#243;s 15 minutos de repouso na posi&#231;&#227;o sentado, em tr&#234;s dias separados de acordo com o JNC 7 <italic>guidelines<sup>26</sup></italic>. A m&#233;dia das tr&#234;s medidas foi considerada para fins de an&#225;lise de dados.</p>
    <p><italic>An&#225;lise sangu&#237;nea -</italic> As amostras sangu&#237;neas foram coletadas em tubos heparinizados para a an&#225;lise da atividade da ecSOD, e em tubos contendo EDTA para an&#225;lise das concentra&#231;&#245;es dos metab&#243;litos do NO (NOx), ap&#243;s um jejum de 12 horas, sendo centrifugadas a 2.000 rpm, a 4&#186; C e por 20 minutos. O supernadante plasm&#225;tico foi imediatamente transferido para <italic>eppendorfs</italic> e congelados a -80&#186; C para an&#225;lise posterior.</p>
    <p><italic>Concentra&#231;&#227;o dos metab&#243;litos de NO</italic><bold>-</bold> O plasma foi ultrafiltrado e os metab&#243;litos do &#243;xido n&#237;trico (NOx) foram analisados por ensaio de Greiss (an&#225;lise das concentra&#231;&#245;es de nitrito ap&#243;s convers&#227;o de nitrato para nitrito), conforme descrito previamente<sup>21,27</sup>. As amostras foram analisadas em duplicatas e a m&#233;dia entre elas foi considerada para fins de an&#225;lise estat&#237;stica. Os coeficientes de varia&#231;&#227;o intra e inter foram de 3,3% e 4,9%, respectivamente.</p>
    <p><italic>Atividade da ecSOD</italic><bold>-</bold> A atividade da ecSOD plasm&#225;tica foi medida atrav&#233;s de kits comerciais da <italic>Cayman Chemicals</italic> (Ann Arbor, MI). As amostras foram analisadas em duplicatas e a m&#233;dia entre elas foi considerada para fins de an&#225;lise estat&#237;stica. Os coeficientes de varia&#231;&#227;o intra e inter foram de 22,0% e 7,0%, respectivamente.</p>
    <p><italic>An&#225;lise gen&#233;tica</italic><bold>-</bold> O DNA dos participantes foi isolado dos leuc&#243;citos utilizando o <italic>kit</italic> da PureGene (Gentra System, Minneapolis, MN). O polimorfismo T-786C do gene da eNOS foi detectado atrav&#233;s de rea&#231;&#245;es em cadeia de polimerase (PCR), utilizando-se os seguintes <italic>primers</italic>: F:5'-CACCCAGGCCCACCCCAACT-<italic>3' and</italic> R:5'-GCCGCAGGTCGACAGAGAG ACT-3'. O DNA foi desnaturado por 5 minutos a 95&#186; C, seguido de 35 ciclos de desnatura&#231;&#227;o (30s, 95&#186; C), anelamento (15s, 54&#186; C) e extens&#227;o (30s, 72&#186; C). O produto do PCR foi digerido pela enzima <italic>MspI</italic> a 37&#186; C, seguido de 4 horas em gel de agarose a 2,0%. O alelo T produz um fragmento de 415 bp, o alelo C produz fragmentos de 370 bp e 45 bp.</p>
    <p>Os portadores do alelo C foram agrupados em um mesmo grupo (TC+CC) sendo comparados com o grupo TT. A frequ&#234;ncia do gen&#243;tipo TT e TC+CC na popula&#231;&#227;o &#233; de aproximadamente 32,0% e 68,0%, respectivamente<sup>28-31</sup>. O alelo C &#233; considerado capaz de gerar efeitos delet&#233;rios no sistema cardiovascular e ambos os gen&#243;tipos (TC e CC) demonstram respostas similares, diferentemente do gen&#243;tipo TT<sup>13,29</sup>. Dessa forma, &#233; apropriado agrupar ambos os gen&#243;tipos TC e CC em um mesmo grupo para an&#225;lise deste estudo.</p>
    <p>
      <bold>Treinamento f&#237;sico aer&#243;bico</bold>
    </p>
    <p>Todos os participantes realizaram um programa supervisionado de exerc&#237;cios f&#237;sicos aer&#243;bico, em esteira ergom&#233;trica, durante 6 meses, tr&#234;s vezes por semana, com intensidade progressiva durante as semanas. Com aquecimento e relaxamento apropriados, a sess&#227;o inicial consistiu de 20 minutos de exerc&#237;cio aer&#243;bico a 50,0% do VO<sub>2</sub>max. A dura&#231;&#227;o do treinamento foi aumentada 5 minutos por semana at&#233; atingir 40 minutos. A partir desse momento, a intensidade era aumentada em 5,0% do VO<sub>2</sub>max a cada semana at&#233; atingir 70,0%. O controle da intensidade foi realizado atrav&#233;s de monitores de frequ&#234;ncia card&#237;aca.</p>
    <p>Apenas os participantes que completaram 75,0% das sess&#245;es de treinamento foram inclu&#237;dos nos resultados finais deste estudo.</p>
    <p>
      <bold>An&#225;lise estat&#237;stica</bold>
    </p>
    <p>Foi realizado uma an&#225;lise descritiva para ambos os grupos (TT e TC+CC) e uma ANOVA <italic>one-way</italic> para detectar diferen&#231;as estat&#237;sticas entre os grupos, levando-se em considera&#231;&#227;o o polimorfismo T-786C do gene da eNOS como vari&#225;vel independente e, como vari&#225;vel dependente, o IMC, a PA, a VO<sub>2</sub>max, a NOx e a atividade da ecSOD. Uma ANOVA <italic>two-way</italic> foi realizada tendo como vari&#225;vel independente o gen&#243;tipo e o exerc&#237;cio f&#237;sico, e, como vari&#225;vel dependente, o FS, a PA e o IMC. A an&#225;lise de correla&#231;&#227;o de Pearson tamb&#233;m foi realizada objetivando detectar poss&#237;veis rela&#231;&#245;es entre as vari&#225;veis analisadas neste estudo.</p>
    <p>Todos os resultados foram expressos em m&#233;dia e erro padr&#227;o da m&#233;dia. O n&#237;vel de signific&#226;ncia foi de p &lt; 0,05. Os dados foram analisados usando o pacote estat&#237;stico <italic>SPSS</italic> 13.0.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>Trinta e duas mulheres pr&#233;-hipertensas foram divididos em dois grupos, de acordo com o polimorfismo T-786C do gene da eNOS (TT - 20 participantes e TC+CC - 12 participantes).</p>
    <p>Nenhuma diferen&#231;a estat&#237;stica foi encontrada entre os grupos nas vari&#225;veis PAS, PAD e IMC, antes e ap&#243;s o programa de exerc&#237;cio f&#237;sico. O VO<sub>2</sub>max aumentou significativamente em ambos os grupos, ap&#243;s o programa de exerc&#237;cio f&#237;sico.</p>
    <p>Os valores de IMC, PA e VO<sub>2</sub>max de ambos os grupos est&#227;o sumarizados na <xref ref-type="table" rid="t1">Tabela 1</xref>.</p>
    <table-wrap id="t1">
      <graphic xlink:href="1678-4170-abc-95-04-0510-00126-gt01.jpg"/></table-wrap>
    <p>Na avalia&#231;&#227;o pr&#233;-treinamento, os n&#237;veis de NOx foram estatisticamente diferentes (p &lt; 0,03) entre os grupos e, como esperado, o grupo TC+CC apresentou valores mais baixos com rela&#231;&#227;o ao grupo TT (<xref ref-type="fig" rid="aop12210f01">Figura 1-A</xref>). A atividade da ecSOD foi 30,0% menor no grupo TC+CC com rela&#231;&#227;o ao grupo TT, mas esta diferen&#231;a n&#227;o apresentou-se estatisticamente significante (<xref ref-type="fig" rid="aop12210f01">Figura 1-B</xref>).</p>
    <p content-type="asset">
      <fig id="aop12210f01">
        <graphic xlink:href="1678-4170-abc-95-04-0510-00126-gf01.jpg"/></fig>
    </p>
    <p>Na avalia&#231;&#227;o p&#243;s-treinamento, o grupo TT manteve os valores plasm&#225;ticos de NOx do momento pr&#233;-treinamento, enquanto que o grupo TC+CC teve um aumento nestes n&#237;veis. Ap&#243;s o programa de exerc&#237;cio f&#237;sico (<xref ref-type="fig" rid="aop12210f01">Figura 1-A</xref>), nenhuma diferen&#231;a significativa foi encontrada entre os grupos, ou seja, a diferen&#231;a encontrada na avalia&#231;&#227;o pr&#233;-treinamento n&#227;o permaneceu significante ap&#243;s o treinamento f&#237;sico.</p>
    <p>Tanto na avalia&#231;&#227;o pr&#233; quanto na avalia&#231;&#227;o p&#243;s-programa de exerc&#237;cio f&#237;sico, nenhuma diferen&#231;a estat&#237;stica foi observada entre os grupos na vari&#225;vel fluxo sangu&#237;neo e na resist&#234;ncia vascular perif&#233;rica. Embora tal resultado n&#227;o tenha alcan&#231;ado diferen&#231;as estat&#237;sticas, o grupo TC+CC apresentou valores maiores de fluxo sangu&#237;neo comparado ao grupo TT na avalia&#231;&#227;o pr&#233;-treinamento, sugerindo uma menor taxa de recupera&#231;&#227;o ao fluxo sangu&#237;neo (<xref ref-type="fig" rid="aop12210f02">Figura 2-A</xref>). Na avalia&#231;&#227;o p&#243;s-treinamento, essa pequena diferen&#231;a n&#227;o foi percebida, apresentando ambos os grupos praticamente o mesmo resultado (<xref ref-type="fig" rid="aop12210f02">Figura 2-B</xref>). Basicamente, a resist&#234;ncia vascular teve o mesmo comportamento do fluxo sangu&#237;neo em rela&#231;&#227;o a ambos os grupos e avalia&#231;&#245;es (<xref ref-type="fig" rid="aop12210f02">Figura 2-C</xref> e <xref ref-type="fig" rid="aop12210f02">2-D</xref>).</p>
    <p content-type="html"><fig id="aop12210f02"><graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/NdH7WGqLVzMM6fC6vJ7yMNk/3ed3c8e2d09f94b93000693ea7f3d2dda0399584.gif"/><graphic xlink:href="1678-4170-abc-95-04-0510-00126-gf02.jpg"/></fig>&#13;
</p>
    <p>A an&#225;lise de correla&#231;&#227;o de Pearson encontrou, na avalia&#231;&#227;o pr&#233;-treinamento para o grupo TT, correla&#231;&#245;es entre NOx e FS-0, tamb&#233;m encontradas entre PAD e as vari&#225;veis de fluxo e resist&#234;ncia (FS-0, RV-0 e RV-1). Na avalia&#231;&#227;o p&#243;s-treinamento, houve correla&#231;&#245;es entre NOx e FS-0 e entre as mudan&#231;as da NOx e as mudan&#231;as na PAD. Para o grupo TC+CC, nenhuma correla&#231;&#227;o significante foi encontrada na avalia&#231;&#227;o pr&#233;-treinamento, mas, na avalia&#231;&#227;o p&#243;s-treinamento, foram encontradas correla&#231;&#245;es entre PAD e FS-1, FS-2 e FS-3 e entre as mudan&#231;as na NOx e as mudan&#231;as no FS-1 e PAD. Todas as correla&#231;&#245;es encontradas est&#227;o resumidas na <xref ref-type="table" rid="t2">Tabela 2</xref>.</p>
    <table-wrap id="t2">
      <graphic xlink:href="1678-4170-abc-95-04-0510-00126-gt02.jpg"/></table-wrap>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>O presente estudo foi desenvolvido para avaliar o potencial efeito do polimorfismo T-786C do gene da eNOS e de 6 meses de um programa regular de exerc&#237;cio f&#237;sico nas respostas hemodin&#226;micas de mulheres idosas pr&#233;-hipertensas.</p>
    <p>O NO possui uma importante fun&#231;&#227;o no controle vascular, especialmente na vasodilata&#231;&#227;o. Tanto a atividade da eNOS quanto os mecanismos respons&#225;veis pela biodisponibilidade do NO contribuem para a manuten&#231;&#227;o de uma adequada concentra&#231;&#227;o de &#243;xido n&#237;trico no vaso sangu&#237;neo, e ambos os mecanismos podem ser afetados pelo exerc&#237;cio f&#237;sico.</p>
    <p>Como esperado, ap&#243;s 6 meses de exerc&#237;cio aer&#243;bio, o resultado do VO<sub>2</sub>max teve um aumento significativo para ambos os grupos, demonstrando que a interven&#231;&#227;o aplicada possuiu est&#237;mulo suficiente para melhorar a capacidade aer&#243;bica das participantes.</p>
    <p>Na press&#227;o arterial, tanto sist&#243;lica quanto diast&#243;lica, nenhuma diferen&#231;a foi encontrada entre os grupos e entre as avalia&#231;&#245;es pr&#233; e p&#243;s-treinamento. Diversos estudos t&#234;m evidenciado um efeito ben&#233;fico do exerc&#237;cio f&#237;sico sobre a press&#227;o arterial. Por exemplo, Hagberg e cols.<sup>32</sup> observaram que o exerc&#237;cio f&#237;sico regular possui a capacidade de diminuir a PA em aproximadamente 75,0% dos indiv&#237;duos hipertensos e que o treinamento com intensidade moderada parece gerar maiores benef&#237;cios do que os de alta intensidade, para tais redu&#231;&#245;es. Higashi e cols.<sup>4</sup> observaram um efeito ben&#233;fico do exerc&#237;cio aer&#243;bico regular nos valores de PA para indiv&#237;duos hipertensos.</p>
    <p>Cabe ressaltar, entretanto, que esses estudos fazem refer&#234;ncia aos efeitos ben&#233;ficos do exerc&#237;cio f&#237;sico em indiv&#237;duos hipertensos, diferentemente do presente estudo, que utilizou indiv&#237;duos pr&#233;-hipertensos, fato que poderia justificar a aus&#234;ncia de diferen&#231;as nos valores de press&#227;o arterial entre as avalia&#231;&#245;es pr&#233; e p&#243;s-treinamento f&#237;sico.</p>
    <p>O polimorfismo T-786C do gene da eNOS &#233; potencialmente importante para o controle cardiovascular, pois tem sido relatado que a presen&#231;a do alelo C diminui a express&#227;o deste gene<sup>33</sup>. No presente estudo, os metab&#243;litos do NO foram significativamente menores para o grupo TC+CC comparado com o grupo TT, na avalia&#231;&#227;o pr&#233;-treinamento. Tal resultado est&#225; em concord&#226;ncia com estudos pr&#233;vios, que tamb&#233;m mostraram que indiv&#237;duos portadores do alelo C para o mesmo polimorfismo possu&#237;am menores concentra&#231;&#245;es de NO<sup>13,34,35</sup>. Por exemplo, Nakayama e cols.<sup>13</sup> observaram que os portadores do alelo C possuem uma diminui&#231;&#227;o de 50,0% da atividade promotora quando comparado aos indiv&#237;duos portadores do alelo T, o qual &#233; consistente com o conceito de que o alelo C pode reduzir as concentra&#231;&#245;es de NO.</p>
    <p>Na avalia&#231;&#227;o p&#243;s-treinamento, nenhuma diferen&#231;a foi encontrada para os valores de NOx no grupo TT. Uma poss&#237;vel explica&#231;&#227;o para esse resultado &#233; que as concentra&#231;&#245;es de NOx dos participantes desse grupo, devido a aus&#234;ncia de diferen&#231;a entre as avalia&#231;&#245;es pr&#233; e p&#243;s-treinamento, j&#225; se encontram em valores ideais para manter o controle da PA. Para o grupo TC+CC, os n&#237;veis de NOx aumentaram ap&#243;s o treinamento aer&#243;bico, mas este aumento n&#227;o foi estatisticamente significante. Tal resultado sugere que, embora o treinamento f&#237;sico realizado n&#227;o tenha sido suficiente para aumentar as concentra&#231;&#245;es de NOx, houve um aumento da atividade da eNOS em indiv&#237;duos portadores do alelo C, pois a diferen&#231;a existente entre os grupos na avalia&#231;&#227;o pr&#233;-treinamento para a NOx, n&#227;o se manteve significante na avalia&#231;&#227;o p&#243;s-treinamento. Esse resultado est&#225; em concord&#226;ncia com v&#225;rios outros estudos que mostraram resultados similares<sup>3,20,36</sup>.</p>
    <p>Existem crescentes evid&#234;ncias para indicar que o exerc&#237;cio cr&#244;nico aumenta o sistema de defesa antioxidante em vasos sangu&#237;neos de humanos atrav&#233;s do aumento da atividade da ecSOD<sup>8,14,37</sup>. O exerc&#237;cio aer&#243;bico pode aumentar a atividade da ecSOD e potencialmente aumentar a biodisponibilidade do NO<sup>11,20</sup>. Entretanto, a atividade biol&#243;gica do NO &#233; dependente dos &#226;nions super&#243;xidos, os quais comprometem a funcionalidade do NO<sup>38</sup>. No presente estudo, a atividade da ecSOD foi menor para o grupo TC+CC comparado ao grupo TT na avalia&#231;&#227;o pr&#233;-treinamento, mas esta diferen&#231;a n&#227;o atingiu signific&#226;ncia estat&#237;stica.</p>
    <p>Ap&#243;s o programa de exerc&#237;cio, ambos os grupos aumentaram proporcionalmente a atividade da ecSOD, mas este aumento permaneceu sem diferen&#231;as estat&#237;sticas entre as avalia&#231;&#245;es e grupos. Dessa forma, sugere-se que a capacidade antioxidante relacionada &#224; biodisponibilidade de NO n&#227;o est&#225; prejudicada nos participantes deste estudo. Esse resultado est&#225; em concord&#226;ncia com o estudo de Di Massimo e cols.<sup>38</sup>; que evidenciaram os valores de NOx independentemente dos valores de ecSOD.</p>
    <p>A libera&#231;&#227;o do NO tem sido considerada como um forte mediador para a hiperemia reativa em art&#233;rias perif&#233;ricas<sup>4</sup>. Desse modo, baixos n&#237;veis de NOx observados no grupo TC+CC, associado &#224;s respostas do FS entre os grupos na avalia&#231;&#227;o pr&#233;-treinamento, est&#227;o em concord&#226;ncia com outros estudos que mostraram resultados similares<sup>24</sup>. Embora nenhuma diferen&#231;a tenha sido encontrada na vari&#225;vel FS, o grupo TT apresentou menores respostas na avalia&#231;&#227;o pr&#233;-treinamento. Tal resultado indica que o grupo TT retornou aos valores de repouso mais rapidamente do que o grupo TC+CC.</p>
    <p>Apesar dos indiv&#237;duos portadores do alelo C apresentarem n&#237;veis menores de NOx e menor atividade da ecSOD na avalia&#231;&#227;o pr&#233;-treinamento, o fluxo sangu&#237;neo ainda permaneceu relativamente elevado. Esse resultado sugere que existem v&#225;rias outras subst&#226;ncias que podem estar contribuindo para esta resposta cardiovascular, como por exemplo, pot&#225;ssio, oxig&#234;nio, di&#243;xido de carbono e adenosina<sup>39,40</sup>. A partir do momento em que os portadores do alelo C possuem alguma disfun&#231;&#227;o vascular, &#233; poss&#237;vel que outros vasodilatadores estejam atuando para controlar as respostas ao fluxo sangu&#237;neo, compensando assim a reduzida produ&#231;&#227;o de NO<sup>17,40</sup>.</p>
    <p>No grupo TC+CC, nenhuma correla&#231;&#227;o foi encontrada na avalia&#231;&#227;o pr&#233;-treinamento entre as vari&#225;veis NOx, FS e PA. Esse resultado pode ser explicado pelo efeito delet&#233;rio do alelo C na regula&#231;&#227;o entre produ&#231;&#227;o e biodisponibilidade do NO. Entretanto, com as correla&#231;&#245;es encontradas na avalia&#231;&#227;o p&#243;s-treinamento entre as vari&#225;veis de press&#227;o arterial, fluxo sangu&#237;neo e NOx, pode-se afirmar que 6 meses de um programa regular de exerc&#237;cios aer&#243;bicos podem contribuir para aumentar a rela&#231;&#227;o existente entre essas vari&#225;veis em indiv&#237;duos portadores do alelo C.</p>
    <p>Ap&#243;s o programa de exerc&#237;cio, aparentemente, o grupo TT possu&#237;a uma resposta normal para a fun&#231;&#227;o vascular, resultando em um reduzido efeito do programa de exerc&#237;cio no repouso e ap&#243;s a hiperemia reativa no FS. Para o grupo TC+CC, embora os valores de fluxo sangu&#237;neo tenham sido mais altos, os indiv&#237;duos tiveram respostas similares comparadas &#224;s respostas do grupo TT. Sendo assim, parece que a capacidade de retorno &#224; homeostase mais rapidamente, no grupo TC+CC na avalia&#231;&#227;o p&#243;s-exerc&#237;cio, pode indicar uma resposta favor&#225;vel do treinamento f&#237;sico, resultando numa melhora da fun&#231;&#227;o vascular perif&#233;rica. Tal resultado est&#225; em concord&#226;ncia com estudos pr&#233;vios que mostraram um efeito ben&#233;fico do exerc&#237;cio f&#237;sico no fluxo sangu&#237;neo em diferentes gen&#243;tipos<sup>4,24,36</sup>.</p>
    <p>Apesar deste estudo possuir algumas limita&#231;&#245;es, como por exemplo, exclus&#227;o de determinadas caracter&#237;sticas populacionais (obesos, diab&#233;ticos, cardiopatas etc.), da an&#225;lise de apenas um polimorfismo e de somente algumas subst&#226;ncias relacionadas tanto &#224; produ&#231;&#227;o quanto &#224; biodisponibilidade do NO, &#233; poss&#237;vel sugerir um efeito ben&#233;fico do exerc&#237;cio f&#237;sico frente as vari&#225;veis analisadas.</p>
    <p>Em resumo, o presente estudo encontrou um efeito positivo do programa de exerc&#237;cio f&#237;sico com rela&#231;&#227;o ao polimorfismo T-786C do gene da eNOS. Isso sugere que um aumento do n&#237;vel de atividade f&#237;sica regular pode melhorar a resposta ao controle cardiovascular, especialmente do NO em portadores do alelo C, contribuindo para a rela&#231;&#227;o entre press&#227;o arterial e fluxo sangu&#237;neo.</p>
    <p>
      <bold>Agradecimentos</bold>
    </p>
    <p>Department of Kinesiology - University of Maryland/Grant KO1AG019640 (M. D. Brown).</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo foi financiado pela Grant KO1AG019640 (M.D. Brown).</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>N&#227;o h&#225; vincula&#231;&#227;o deste estudo a programas de p&#243;s-gradua&#231;&#227;o.</p>
    <p>
      <fn id="back" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p> Anderson Saranz Zago </p>
        <p> Av. Bandeirantes, 3900 </p>
        <p> Monte Alegre - 14040-900 </p>
        <p> Ribeir&#227;o Preto, SP - Brasil </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="aszago@usp.br">aszago@usp.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 18/05/09; revisado recebido em 26/01/10; aceito em 12/04/10.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Channon KM ,    Guzik TJ. Mechanisms of superoxide production in human blood vessels: relationship    to endothelial dysfunction, clinical and genetic risk factors. J Physiol Pharmacol.    2002; 53 (4 Pt 1): 515-24.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors</article-title>
          <source>J Physiol Pharmacol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>515</fpage>
          <lpage>24</lpage>
          <issue>4</issue>
          <volume>53</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Channon</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Guzik</surname>
              <given-names>TJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Rush JW, Denniss    SG, Graham DA. Vascular nitric oxide and oxidative stress: determinants of endothelial    adaptations to cardiovascular disease and to physical activity. Can J Appl Physiol.    2005; 30 (4): 442-74.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Vascular nitric oxide and oxidative stress: determinants of endothelial adaptations to cardiovascular disease and to physical activity</article-title>
          <source>Can J Appl Physiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>442</fpage>
          <lpage>74</lpage>
          <issue>4</issue>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rush</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Denniss</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Graham</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Sessa WC, Pritchard    K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary    vascular nitric oxide production and endothelial cell nitric oxide synthase    gene expression. Circ Res. 1994; 74 (2): 349-53.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression</article-title>
          <source>Circ Res</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>349</fpage>
          <lpage>53</lpage>
          <issue>2</issue>
          <volume>74</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sessa</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Pritchard</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Seyedi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hintze</surname>
              <given-names>TH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Higashi Y, Sasaki    S, Sasaki N, Nakagawa K, Ueda T, Yoshimizu A, et al. Daily aerobic exercise    improves reactive hyperemia in patients with essential hypertension. Hypertension.    1999; 33 (1 Pt 2): 591-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Daily aerobic exercise improves reactive hyperemia in patients with essential hypertension</article-title>
          <source>Hypertension</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>591</fpage>
          <lpage>7</lpage>
          <issue>1</issue>
          <volume>33</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Higashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sasaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sasaki</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nakagawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ueda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yoshimizu</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Moncada S. Nitric    oxide. J Hypertens Suppl. 1994; 12 (10): S35-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Nitric oxide</article-title>
          <source>J Hypertens Suppl</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>S35</fpage>
          <lpage>9</lpage>
          <issue>10</issue>
          <volume>12</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Moncada</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Zago AS, Zanesco    A. Nitric oxide, cardiovascular disease and physical exercise. Arq Bras Cardiol.    2006; 87 (6): e264-70.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Nitric oxide, cardiovascular disease and physical exercise</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>e264</fpage>
          <lpage>70</lpage>
          <issue>6</issue>
          <volume>87</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Zago</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Zanesco</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Erbs S, Baither    Y, Linke A, Adams V, Shu Y, Lenk K, et al. Promoter but not exon 7 polymorphism    of endothelial nitric oxide synthase affects training-induced correction of    endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2003; 23 (10): 1814-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Promoter but not exon 7 polymorphism of endothelial nitric oxide synthase affects training-induced correction of endothelial dysfunction</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1814</fpage>
          <lpage>9</lpage>
          <issue>10</issue>
          <volume>23</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Erbs</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Baither</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Linke</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Shu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Lenk</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Guzik TJ, Olszanecki    R, Sadowski J, Kapelak B, Rudzinski P, Jopek A, et al. Superoxide dismutase    activity and expression in human venous and arterial bypass graft vessels. J    Physiol Pharmacol. 2005; 56 (2): 313-23.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Superoxide dismutase activity and expression in human venous and arterial bypass graft vessels</article-title>
          <source>J Physiol Pharmacol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>313</fpage>
          <lpage>23</lpage>
          <issue>2</issue>
          <volume>56</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Guzik</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Olszanecki</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sadowski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kapelak</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Rudzinski</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Jopek</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Heltianu C,    Costache G, Gafencu A, Diaconu M, Bodeanu M, Cristea C, et al. Relationship    of eNOS gene variants to diseases that have in common an endothelial cell dysfunction.    J Cell Mol Med. 2005; 9 (1): 135-42.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Relationship of eNOS gene variants to diseases that have in common an endothelial cell dysfunction</article-title>
          <source>J Cell Mol Med</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>135</fpage>
          <lpage>42</lpage>
          <issue>1</issue>
          <volume>9</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Heltianu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Costache</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gafencu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Diaconu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bodeanu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cristea</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Lauer T, Kleinbongard    P, Kelm M. Indexes of NO bioavailability in human blood. News Physiol Sci. 2002;    17: 251-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Indexes of NO bioavailability in human blood</article-title>
          <source>News Physiol Sci</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>251</fpage>
          <lpage>5</lpage>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lauer</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kleinbongard</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kelm</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Rutherford    PA. Genetic influences in human hypertension. J Hypertens. 2003; 21 (1): 19-22.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Genetic influences in human hypertension</article-title>
          <source>J Hypertens</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>19</fpage>
          <lpage>22</lpage>
          <issue>1</issue>
          <volume>21</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rutherford</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Touyz RM, Schiffrin    EL. Reactive oxygen species in vascular biology: implications in hypertension.    Histochem Cell Biol. 2004; 122 (4): 339-52.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Reactive oxygen species in vascular biology: implications in hypertension</article-title>
          <source>Histochem Cell Biol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>339</fpage>
          <lpage>52</lpage>
          <issue>4</issue>
          <volume>122</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Touyz</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Schiffrin</surname>
              <given-names>EL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Nakayama M,    Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, et al. T-786&gt;C    mutation in the 5'-flanking region of the endothelial nitric oxide synthase    gene is associated with coronary spasm. Circulation. 1999; 99 (22): 2864-70.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>T-786-&gt;C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm</article-title>
          <source>Circulation</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>2864</fpage>
          <lpage>70</lpage>
          <issue>22</issue>
          <volume>99</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nakayama</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yasue</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yoshimura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shimasaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kugiyama</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ogawa</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Campo S, Sardo    AM, Campo GM, D'Ascola A, Avenoso A, Castaldo M, et al. Extracellular superoxide    dismutase (EC-SOD) gene mutations screening in a sample of Mediterranean population.    Mutat Res. 2005; 578 (1-2): 143-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Extracellular superoxide dismutase (EC-SOD) gene mutations screening in a sample of Mediterranean population</article-title>
          <source>Mutat Res</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>143</fpage>
          <lpage>8</lpage>
          <issue>1-2</issue>
          <volume>578</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Campo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sardo</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Campo</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>D'Ascola</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Avenoso</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Castaldo</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Landmesser    U, Harrison DG, Drexler H. Oxidant stress-a major cause of reduced endothelial    nitric oxide availability in cardiovascular disease. Eur J Clin Pharmacol. 2006;    62 (Suppl 1): 13-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Oxidant stress-a major cause of reduced endothelial nitric oxide availability in cardiovascular disease</article-title>
          <source>Eur J Clin Pharmacol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>13</fpage>
          <lpage>9</lpage>
          <volume>62</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Landmesser</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Drexler</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Vaneckova I,    Kramer HJ, Novotna J, Kazdova L, Opocensky M, Bader M, et al. Roles of nitric    oxide and oxidative stress in the regulation of blood pressure and renal function    in prehypertensive Ren-2 transgenic rats. Kidney Blood Press Res. 2005; 28 (2):    117-26.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats</article-title>
          <source>Kidney Blood Press Res</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>117</fpage>
          <lpage>26</lpage>
          <issue>2</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Vaneckova</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kramer</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Novotna</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kazdova</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Opocensky</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bader</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Mombouli JV,    Vanhoutte PM. Endothelial dysfunction: from physiology to therapy. J Mol Cell    Cardiol. 1999; 31 (1): 61-74.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Endothelial dysfunction: from physiology to therapy</article-title>
          <source>J Mol Cell Cardiol</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>61</fpage>
          <lpage>74</lpage>
          <issue>1</issue>
          <volume>31</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mombouli</surname>
              <given-names>JV</given-names>
            </name>
            <name>
              <surname>Vanhoutte</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Touyz RM. Reactive    oxygen species, vascular oxidative stress, and redox signaling in hypertension:    what is the clinical significance? Hypertension. 2004; 44 (3): 248-52.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?</article-title>
          <source>Hypertension</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>248</fpage>
          <lpage>52</lpage>
          <issue>3</issue>
          <volume>44</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Touyz</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Park JY, Ferrell    RE, Park JJ, Hagberg JM, Phares DA, Jones JM, et al. NADPH oxidase p22phox gene    variants are associated with systemic oxidative stress biomarker responses to    exercise training. J Appl Physiol. 2005; 99 (5): 1905-11.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>NADPH oxidase p22phox gene variants are associated with systemic oxidative stress biomarker responses to exercise training</article-title>
          <source>J Appl Physiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>1905</fpage>
          <lpage>11</lpage>
          <issue>5</issue>
          <volume>99</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Ferrell</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Hagberg</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Phares</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Higashi Y,    Yoshizumi M. Exercise and endothelial function: role of endothelium-derived    nitric oxide and oxidative stress in healthy subjects and hypertensive patients.    Pharmacol Ther. 2004; 102 (1): 87-96.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise and endothelial function: role of endothelium-derived nitric oxide and oxidative stress in healthy subjects and hypertensive patients</article-title>
          <source>Pharmacol Ther</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>87</fpage>
          <lpage>96</lpage>
          <issue>1</issue>
          <volume>102</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Higashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yoshizumi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Weiss EP, Park    JJ, McKenzie JA, Park JY, Kulaputana O, Brown MD, et al. Plasma nitrate/nitrite    response to an oral glucose load and the effect of endurance training. Metabolism.    2004; 53 (5): 673-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Plasma nitrate/nitrite response to an oral glucose load and the effect of endurance training</article-title>
          <source>Metabolism</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>673</fpage>
          <lpage>9</lpage>
          <issue>5</issue>
          <volume>53</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Weiss</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>McKenzie</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Kulaputana</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Feairheller    DL, Brown MD, Park JY, Brinkley TE, Basu S, Hagberg JM, et al. Exercise training,    NADPH oxidase p22phox gene polymorphisms, and hypertension. Med Sci Sports Exerc.    2009; 41 (7): 1421-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise training, NADPH oxidase p22phox gene polymorphisms, and hypertension</article-title>
          <source>Med Sci Sports Exerc</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>1421</fpage>
          <lpage>8</lpage>
          <issue>7</issue>
          <volume>41</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Feairheller</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Brinkley</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Basu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hagberg</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Jones JM, Dowling    TC, Park JJ, Phares DA, Park JY, Obisesan TO, et al. Differential aerobic exercise-induced    changes in plasma aldosterone between African Americans and Caucasians. Exp    Physiol. 2007; 92 (5): 871-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Differential aerobic exercise-induced changes in plasma aldosterone between African Americans and Caucasians</article-title>
          <source>Exp Physiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>871</fpage>
          <lpage>9</lpage>
          <issue>5</issue>
          <volume>92</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Dowling</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Phares</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Obisesan</surname>
              <given-names>TO</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Data SA, Roltsch    MH, Hand B, Ferrell RE, Park JJ, Brown MD. eNOS T-786C genotype, physical activity,    and peak forearm blood flow in females. Med Sci Sports Exerc. 2003; 35 (12):    1991-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>eNOS T-786C genotype, physical activity, and peak forearm blood flow in females</article-title>
          <source>Med Sci Sports Exerc</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1991</fpage>
          <lpage>7</lpage>
          <issue>12</issue>
          <volume>35</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Data</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Roltsch</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Hand</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ferrell</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Hand BD, Roth    SM, Roltsch MH, Park JJ, Kostek MC, Ferrell RE, et al. AMPD1 gene polymorphism    and the vasodilatory response to ischemia. Life Sci. 2006; 79 (15): 1413-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>AMPD1 gene polymorphism and the vasodilatory response to ischemia</article-title>
          <source>Life Sci</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>1413</fpage>
          <lpage>8</lpage>
          <issue>15</issue>
          <volume>79</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hand</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Roltsch</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Kostek</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Ferrell</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Chobanian AV,    Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report    of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment    of High Blood Pressure. Hypertension. 2003; 42 (6): 1206-52.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure</article-title>
          <source>Hypertension</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1206</fpage>
          <lpage>52</lpage>
          <issue>6</issue>
          <volume>42</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chobanian</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Bakris</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Cushman</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Izzo</surname>
              <given-names>JL Jr</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Brown MD, Hogikyan    RV, Dengel DR, Supiano MA. Sodium-sensitive hypertension is not associated with    higher sympathetic nervous system activity in older hypertensive humans. Am    J Hypertens. 2000; 13 (8): 873-83.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Sodium-sensitive hypertension is not associated with higher sympathetic nervous system activity in older hypertensive humans</article-title>
          <source>Am J Hypertens</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>873</fpage>
          <lpage>83</lpage>
          <issue>8</issue>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Hogikyan</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Dengel</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Supiano</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Tanus-Santos    JE, Desai M, Flockhart DA. Effects of ethnicity on the distribution of clinically    relevant endothelial nitric oxide variants. Pharmacogenetics. 2001; 11 (8):    719-25.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants</article-title>
          <source>Pharmacogenetics</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>719</fpage>
          <lpage>25</lpage>
          <issue>8</issue>
          <volume>11</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Tanus-Santos</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Desai</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Flockhart</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Rossi GP, Taddei    S, Virdis A, Cavallin M, Ghiadoni L, Favilla S, et al. The T-786C and Glu298Asp    polymorphisms of the endothelial nitric oxide gene affect the forearm blood    flow responses of Caucasian hypertensive patients. J Am Coll Cardiol. 2003;    41(6): 938-45.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>938</fpage>
          <lpage>45</lpage>
          <issue>6</issue>
          <volume>41</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rossi</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Taddei</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Virdis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cavallin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ghiadoni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Favilla</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. Nagassaki S,    Metzger IF, Souza-Costa DC, Marroni AS, Uzuelli JA e Tanus-Santos JE. eNOS genotype    is without effect on circulating nitrite/nitrate level in healthy male population.    Thromb Res. 2005; 115 (5): 375-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population</article-title>
          <source>Thromb Res</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>375</fpage>
          <lpage>9</lpage>
          <issue>5</issue>
          <volume>115</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nagassaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Metzger</surname>
              <given-names>IF</given-names>
            </name>
            <name>
              <surname>Souza-Costa</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Marroni</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Uzuelli JA e Tanus-Santos</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31. Sandrim VC.    Influence of T-786C polymorphism on the promoter activity of eNOS. Clin Chim    Acta. 2006; 367 (1-2): 208.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Influence of T-786C polymorphism on the promoter activity of eNOS</article-title>
          <source>Clin Chim Acta</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>208</fpage>
          <issue>1-2</issue>
          <volume>367</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sandrim</surname>
              <given-names>VC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <mixed-citation>32. Hagberg JM,    Park JJ, Brown MD. The role of exercise training in the treatment of hypertension:    an update. Sports Med. 2000; 30 (3): 193-206.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The role of exercise training in the treatment of hypertension: an update</article-title>
          <source>Sports Med</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>193</fpage>
          <lpage>206</lpage>
          <issue>3</issue>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hagberg</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B33">
        <mixed-citation>33. Wang XL, Wang    J. Endothelial nitric oxide synthase gene sequence variations and vascular disease.    Mol Genet Metab. 2000; 70 (4): 241-51.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Endothelial nitric oxide synthase gene sequence variations and vascular disease</article-title>
          <source>Mol Genet Metab</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>241</fpage>
          <lpage>51</lpage>
          <issue>4</issue>
          <volume>70</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>XL</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B34">
        <mixed-citation>34. Dengel DR,    Brown MD, Ferrell RE, Reynolds TH, Supiano MA. A preliminary study on T-786C    endothelial nitric oxide synthase gene and renal hemodynamic and blood pressure    responses to dietary sodium. Physiol Res. 2007; 56: 393-401.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A preliminary study on T-786C endothelial nitric oxide synthase gene and renal hemodynamic and blood pressure responses to dietary sodium</article-title>
          <source>Physiol Res</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>393</fpage>
          <lpage>401</lpage>
          <volume>56</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Dengel</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Ferrell</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Supiano</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B35">
        <mixed-citation>35. Metzger IF,    Souza-Costa DC, Marroni AS, Nagassaki S, Desta Z, Flockhart DA, et al. Endothelial    nitric oxide synthase gene haplotypes associated with circulating concentrations    of nitric oxide products in healthy men. Pharmacogenet Genomics. 2005; 15 (8):    565-70.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men</article-title>
          <source>Pharmacogenet Genomics</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>565</fpage>
          <lpage>70</lpage>
          <issue>8</issue>
          <volume>15</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Metzger</surname>
              <given-names>IF</given-names>
            </name>
            <name>
              <surname>Souza-Costa</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Marroni</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Nagassaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Desta</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Flockhart</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B36">
        <mixed-citation>36. Kingwell BA.    Nitric oxide-mediated metabolic regulation during exercise: effects of training    in health and cardiovascular disease. Faseb J. 2000; 14 (12): 1685-96.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease</article-title>
          <source>Faseb J</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>1685</fpage>
          <lpage>96</lpage>
          <issue>12</issue>
          <volume>14</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kingwell</surname>
              <given-names>BA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B37">
        <mixed-citation>37. Ohta M, Nanri    H, Matsushima Y, Sato Y, Ikeda M. Blood pressure-lowering effects of lifestyle    modification: possible involvement of nitric oxide bioavailability. Hypertens    Res. 2005; 28 (10): 779-86.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Blood pressure-lowering effects of lifestyle modification: possible involvement of nitric oxide bioavailability</article-title>
          <source>Hypertens Res</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>779</fpage>
          <lpage>86</lpage>
          <issue>10</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ohta</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nanri</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Matsushima</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ikeda</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B38">
        <mixed-citation>38. Di Massimo    C, Scarpelli P, Di Lorenzo N, Caimi G, Di Orio F, Ciancarelli MG. Impaired plasma    nitric oxide availability and extracellular superoxide dismutase activity in    healthy humans with advancing age. Life Sci. 2006; 78 (11): 1163-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Impaired plasma nitric oxide availability and extracellular superoxide dismutase activity in healthy humans with advancing age</article-title>
          <source>Life Sci</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>1163</fpage>
          <lpage>7</lpage>
          <issue>11</issue>
          <volume>78</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Di Massimo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Scarpelli</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Di Lorenzo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Caimi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Di Orio</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ciancarelli</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B39">
        <mixed-citation>39. Koramaz I,    Ozkan M, Altun G, Guven KY, Kadioglu Duman M, Kalyoncu NI, et al. Effects of    papaverine and carbon dioxide alone or in combination on the blood flow of internal    thoracic artery. J Thorac Cardiovasc Surg. 2006; 132 (5): 1126-30.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effects of papaverine and carbon dioxide alone or in combination on the blood flow of internal thoracic artery</article-title>
          <source>J Thorac Cardiovasc Surg</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>1126</fpage>
          <lpage>30</lpage>
          <issue>5</issue>
          <volume>132</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Koramaz</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ozkan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Altun</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Guven</surname>
              <given-names>KY</given-names>
            </name>
            <name>
              <surname>Kadioglu Duman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kalyoncu</surname>
              <given-names>NI</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B40">
        <mixed-citation>40. Juel C, Olsen    S, Rentsch RL, Gonzalez-Alonso J, Rosenmeier JB. K+ as a vasodilator in resting    human muscle: implications for exercise hyperaemia. Acta Physiol (Oxf). 2007;    190 (4): 311-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>K+ as a vasodilator in resting human muscle: implications for exercise hyperaemia</article-title>
          <source>Acta Physiol (Oxf)</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>311</fpage>
          <lpage>8</lpage>
          <issue>4</issue>
          <volume>190</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Juel</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rentsch</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Gonzalez-Alonso</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rosenmeier</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Effect of physical activity and t-786C polymorphism in blood pressure and blood flow in the elderly</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: The T-786C polymorphism of the gene for endothelial nitric oxide synthase (eNOS) and superoxide anion production may reduce production and bioavailability of nitric oxide, affecting the degree of vasodilation. This effect can be reversed by exercise. OBJECTIVE: To investigate the influence of aerobic training and T-786C polymorphism in the concentrations of nitric oxide metabolites (NOx) in blood flow (BF) and blood pressure (BP). METHODS: Thirty-two elderly pre-hypertensive women (59 &#177; 6 years old) were divided into two groups according to the T-786C polymorphism (TT and TC + CC). We analyzed the concentrations of NOx (plasma) and blood flow by venous occlusion plethysmography at rest, 1, 2 and 3 minutes post-occlusion (BF-0, BF-1 BF-2 BF-3, respectively). Evaluations were performed before and after 6 months of a program of aerobic exercise. RESULTS: In the pre-training evaluations, NOx levels were lower in TC + CC group than in TT group. The TT group showed correlations between NOx and BF-0 (r = 0.6) and diastolic blood pressure (DBP) and BF-0 (r = -0.7), but no correlation was found in TC + CC group. In the post-training evaluations, there were correlations between NOx and BF-0 (r = 0.6) and the changes in NOx and DBP (r = -0.6) in TT group. There were also correlations between DBP and BF-1 (r = -0.8), DBP, and BF-2 (r = -0.6), DBP, and BF-3 (r = -0.6), in the changes between NOx and BF-1 (r = 0.8) and changes in NOx and DBP (r = -0.7) in TC + CC group. CONCLUSION: It was concluded that 6 months of aerobic exercise can increase the relationship between NO, BP and BF in elderly of allele C carriers.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Nitric oxide</kwd>
        <kwd>superoxide dismutase</kwd>
        <kwd>exercise</kwd>
        <kwd>blood pressure</kwd>
        <kwd>aged</kwd>
        <kwd>polymorphism</kwd>
        <kwd>genetic</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p>
        <fn id="top-body2">
          <label>
            <bold>Effect of physical activity and T-786C polymorphism in blood pressure and blood flow in the elderly</bold>
          </label>
          <p>
            <bold>Anderson Saranz Zago<sup>I</sup>; Eduardo Kokubun<sup>II</sup>; Nicola Fenty-Stewart<sup>III</sup>; Joon-Young Park<sup>III</sup>; Selasi Attipoe<sup>IV</sup>; James Hagberg<sup>IV</sup>; Michael Brown<sup>III</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Escola de Educa&#231;&#227;o F&#237;sica e Esportes - USP, Ribeir&#227;o Preto, SP - Brazil</p>
      <p><sup>II</sup>Departamento de Educa&#231;&#227;o F&#237;sica - UNESP, Rio Claro, SP - Brazil</p>
      <p><sup>III</sup>Department of Kinesiology - Temple University, Philadelphia - USA</p>
      <p><sup>IV</sup>Department of Kinesiology - University of Maryland, College Park - USA</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND:</bold> The T-786C polymorphism of the gene for endothelial nitric oxide synthase (eNOS) and superoxide anion production may reduce production and bioavailability of nitric oxide, affecting the degree of vasodilation. This effect can be reversed by exercise.</p>
      <p><bold>OBJECTIVE:</bold> To investigate the influence of aerobic training and T-786C polymorphism in the concentrations of nitric oxide metabolites (NOx) in blood flow (BF) and blood pressure (BP).</p>
      <p><bold>METHODS:</bold> Thirty-two elderly pre-hypertensive women (59 &#177; 6 years old) were divided into two groups according to the T-786C polymorphism (TT and TC + CC). We analyzed the concentrations of NOx (plasma) and blood flow by venous occlusion plethysmography at rest, 1, 2 and 3 minutes post-occlusion (BF-0, BF-1 BF-2 BF-3, respectively). Evaluations were performed before and after 6 months of a program of aerobic exercise.</p>
      <p><bold>RESULTS:</bold> In the pre-training evaluations, NOx levels were lower in TC + CC group than in TT group. The TT group showed correlations between NOx and BF-0 (r = 0.6) and diastolic blood pressure (DBP) and BF-0 (r = -0.7), but no correlation was found in TC + CC group. In the post-training evaluations, there were correlations between NOx and BF-0 (r = 0.6) and the changes in NOx and DBP (r = -0.6) in TT group. There were also correlations between DBP and BF-1 (r = -0.8), DBP, and BF-2 (r = -0.6), DBP, and BF-3 (r = -0.6), in the changes between NOx and BF-1 (r = 0.8) and changes in NOx and DBP (r = -0.7) in TC + CC group.</p>
      <p><bold>CONCLUSION:</bold> It was concluded that 6 months of aerobic exercise can increase the relationship between NO, BP and BF in elderly of allele C carriers.</p>
      <p><bold>Key words:</bold> Nitric oxide; superoxide dismutase; exercise; blood pressure; aged; polymorphism, genetic.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>Nitric oxide (NO) produced by endothelial nitric oxide synthase (eNOS) has an important role in cardiovascular control, especially for vasodilation<sup>1,2</sup>. When eNOS is activated, the metabolism of L-arginine is increased generating the formation of L-citrulline and NO by endothelial cells<sup>3-5</sup>. Once produced, NO migrates to the vascular smooth muscle cell generating increased activity of guanylate cyclase, resulting in decreased calcium and vascular smooth muscle relaxation<sup>5,6</sup>.</p>
      <p>In the blood vessel, among the mechanisms involved in maintaining adequate concentrations of NO, it may be noted the activity of eNOS and the bioavailability of NO<sup>7-12</sup>.</p>
      <p>The activity of eNOS may be genetically determined and some polymorphisms have been identified as potential candidates for the development of arterial hypertension<sup>9</sup>. For example, the C allele of T-786C polymorphism in the promoter region of the eNOS gene has been able to decrease the promoter and transcriptional activity of this gene, reducing the production of NO<sup>7,13</sup>.</p>
      <p>The bioavailability of NO is closely related to production of superoxide anion (O<sub>2</sub><sup>-</sup>) produced by the endothelium, the adventitia layer and vascular smooth muscle cell<sup>1,14-18</sup>. Both physical and humoral factors, such as shear stress, can modulate the activity of NAD(P)H oxidase and induce the production of O<sub>2</sub><sup>-12,19</sup>. The increase of O<sub>2</sub><sup>-</sup> in the cardiovascular system may cause endothelial dysfunction and increased vascular contractility<sup>2,12</sup>. When produced in excess, O<sub>2</sub><sup>-</sup> reacts with NO producing peroxynitrite (ONOO<sup>-</sup>), decreasing the bioavailability of NO<sup>2</sup>.</p>
      <p>Opposed to the effects of both mechanisms (gene polymorphisms of eNOS and of the production of O<sub>2</sub><sup>-</sup>), aerobic exercise has been indicated as a major stimulus to combat these endothelial disorders<sup>2,19,20</sup>. The shear stress induced by the increase in blood flow, especially during physical exercises, may benefit the cardiovascular control mechanism in almost two mechanisms. First, the increased expression of eNOS and thus NO production, and second, the production of extracellular superoxide dismutase (ecSOD), which has the ability to react with O<sub>2</sub><sup>-</sup>; potentially increasing the availability of NO for vascular smooth muscle cell<sup>11,20</sup>.</p>
      <p>So, exercise can regulate NO-mediated vasodilation by lowering the blood pressure values in most hypertensive subjects<sup>2</sup>. However, there is still controversy among studies with respect to the beneficial effects of physical exercise in increasing concentrations of NO and the vasodilator response in individuals carrying eNOS gene polymorphism<sup>11</sup>.</p>
      <p>The objective of this study was to investigate the influence of regular physical activity and T-786C polymorphism of the eNOS gene have in circulating levels of NO metabolites (NOx), the activity of ecSOD, in blood flow (BF) and pressure (BP) in pre-hypertensive elderly women.</p>
      <p>
        <bold>Materials and methods</bold>
      </p>
      <p>
        <bold>Participants</bold>
      </p>
      <p>This study was approved by the Ethics Committee of the University of Maryland College Park/USA and by the Ethics in Research Institute of Biosciences/CEP-IB-UNESP.</p>
      <p>On their first visit to the lab, all participants signed an informed consent form. The subjects were 32 apparently healthy women between 50-70 years old, sedentary, pre-hypertensive (without medication), non diabetic and non smokers. Women with overweight and obesity (BMI &gt; 37 kg/m<sup>2</sup>) were excluded from the study to avoid the interference of these variables in this study results.</p>
      <p>The participants were divided into two groups according to the results of analysis of polymorphism of the eNOS gene, being classified as TT and TC + CC. Women in post-menopausal (83.0% of total participants), who were using hormone replacement therapy (45.0% of participants), maintained medications during the study.</p>
      <p>
        <bold>Procedures</bold>
      </p>
      <p>All participants performed the Bruce treadmill test with ECG for detection of cardiovascular disease, as described previously<sup>21</sup>. A diet record was performed and participants were instructed to keep the phase 1 diet of the American Heart Association (AHA), with stable weight for at least 3 weeks, as described previously<sup>22</sup>. All basic tests were performed before and after 6 months of a physical training program and the difference between the pre and post evaluations (post - pre = difference) was also used for the purposes of verifying the effectiveness of training in each variable studied.</p>
      <p>
        <bold>Basic tests</bold>
      </p>
      <p>The evaluation encompassed maximum oxygen consumption test (VO<sub>2</sub>max), blood flow (BF), blood pressure (BP) and blood collection.</p>
      <p><italic>Maximal oxygen consumption (VO<sub>2</sub>max)</italic> - was determined by voluntary exhaustion test, through a system of indirect calorimetry (model 2300, Hans Rudolph Inc., Kansas City, Missouri) and gas analyzer (model 1100, Perkin Elmer, Inc Danbury, Conn.) connected to a computer. VO<sub>2</sub>max was determined when two of three criteria were met: respiratory exchange &gt; 1.1, heart rate &gt; 220 - age, and an increase greater than 150 ml min<sup>-1</sup> in VO<sub>2</sub> during the last two minutes of test<sup>23</sup>. During the test, heart rate (HR), BP and ECG were monitored.</p>
      <p><italic>Blood flow</italic> - All participants were conducted to the laboratory between 7:00 and 9:00 am after fasting for 12 hours. The participants remained at rest in a lying position for 15 minutes, and blood flow was measured at the nondominant forearm using the technique of venous occlusion plethysmography. Briefly, using an automatic inflator, a small cuff was inflated around the wrist and a larger cuff around the upper arm (humerus) to 180 mmHg and 55 mmHg, respectively. To create ischemia of the arm, the cuff was inflated to 50 mmHg above systolic blood pressure at rest and maintained for 5 minutes. After this period of ischemia, the wrist cuff was inflated again and the arm was inflated to 55 mmHg, every minute<sup>24</sup>. It has been shown that the tissue has the ability to recover from ischemia in three minutes and that peak vasodilation occurs in about one minute after the release of the cuff<sup>24,25</sup>. Thus, BF was measured at rest (BF-0) and one, two and three minutes of reactive hyperemia (BF-1 BF-2 and BF-3, respectively), after 5 minutes of ischemia. The HR and BP were measured simultaneously in the other arm. Vascular resistance (VR) of the arm was calculated with the mean BP divided by the BF.</p>
      <p><italic>Casual blood pressure</italic> - The systolic and diastolic BP (SBP and DBP) were measured after 15 minutes of rest in the sitting position on three separate days according to the JNC 7 guidelines<sup>26</sup>. The mean of three measurements was considered for data analysis.</p>
      <p><italic>Blood analysis</italic> - Blood samples were collected in heparinized tubes for analysis of ecSOD activity, and in tubes containing EDTA for analysis of concentrations of NO metabolites (NOx), after fasting of 12 hours, and centrifuged at 2000 rpm, at 4&#186;C for 20 minutes. The plasma supernatant was immediately transferred to Eppendorf tubes and frozen at -80 &#186;C for later analysis.</p>
      <p><italic>Concentration of the metabolites of NO</italic> - Plasma was ultrafiltered and nitric oxide metabolites (NOx) were measured by Greiss assay (analysis of concentrations of nitrite after conversion of nitrate to nitrite), as described previously<sup>21,27</sup>. The samples were analyzed in duplicates and the average between them was considered for statistical analysis. The coefficients of variation were within and between 3.3% and 4.9% respectively.</p>
      <p><italic>EcSOD activity</italic> - The activity of plasma ecSOD levels was measured using commercial kits from Cayman Chemicals (Ann Arbor, MI). The samples were analyzed in duplicates and the average between them was considered for statistical analysis. The coefficients of variation within and between were 22.0% and 7.0% respectively.</p>
      <p><italic>Genetic analysis</italic> - The DNA of the participants was isolated from leucocytes using PureGene kit (Gentra System, Minneapolis, MN). The T-786C polymorphism of the eNOS gene was detected by polymerase chain reaction (PCR) using the following primers: F: 5'-CACCCAGGCCCACCCCAACT-3' and R:5'-GCCGCAGGTCGACAGAGAG ACT-3'. The DNA was denatured for 5 minutes to 95&#186;C, followed by 35 cycles of denaturation (30s, 95&#186;C), annealing (15s, 54&#186;C) and extension (30s, 72&#186;C). The PCR product was digested by the enzyme MspI at 37&#186;C, followed by four hours in agarose gel 2.0%. The T allele yields a fragment of 415 bp, and the C allele yields fragments of 370 bp and 45 bp.</p>
      <p>C allele carriers were grouped into the same group (TC + CC) and compared with the TT group. The frequency of genotype TT and TC + CC in the population is approximately 32.0% and 68.0%, respectively<sup>28-31</sup>. The C allele is considered capable of generating deleterious effects on the cardiovascular system and both genotypes (TC and CC) showed similar responses, unlike genotype TT<sup>13,29</sup>. Thus, it is appropriate to group both TC and CC genotypes in the same group for analysis in this study.</p>
      <p>
        <bold>Aerobic physical training</bold>
      </p>
      <p>All participants underwent a supervised program of aerobic exercise on a treadmill for six months, three times a week, with gradual intensity increase over the weeks. With appropriate heating and relaxation, the initial session consisted of 20 minutes of aerobic exercise to 50.0% of VO<sub>2</sub>max. The duration of training was increased 5 minutes per week until reaching 40 minutes. Thereafter, the intensity was increased by 5.0% of VO<sub>2</sub>max every week until it reaches 70.0%. The intensity control was performed by heart rate monitors.</p>
      <p>Only participants who completed 75.0% of the training sessions were included in the final results of this study.</p>
      <p>
        <bold>Statistical analysis</bold>
      </p>
      <p>A descriptive analysis was performed for both groups (TT and TC + CC) and a one-way ANOVA to detect statistical differences between groups, taking into account the T-786C polymorphism of the eNOS gene as an independent variable and as dependent variable, BMI, BP, VO<sub>2</sub>max, the NOx and activity of ecSOD. A two-way ANOVA was performed with genotype as independent variables and physical activity, and as a dependent variable, BF, BP and BMI. The Pearson correlation analysis was also carried out aiming at detecting possible relationships between the variables analyzed in this study.</p>
      <p>All results are expressed as mean and standard error of mean. The significance level was p &lt; 0.05. Data were analyzed using the statistical package SPSS 13.0.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>Thirty-two pre-hypertensive women were divided into two groups according to the T-786C polymorphism of the eNOS gene (TT - 20 participants and TC + CC - 12 participants).</p>
      <p>No statistical difference was found between groups in SBP, DBP and BMI, variables before and after the exercise program. VO<sub>2</sub>max significantly increased in both groups after the exercise program.</p>
      <p>The values of BMI, BP and VO<sub>2</sub>max of both groups are summarized in <xref ref-type="table" rid="t1-body2">Table 1</xref>.</p>
      <table-wrap id="t1-body2">
        <graphic xlink:href="1678-4170-abc-95-04-0510-00126-gt01-en.jpg"/></table-wrap>
      <p>In the pre-training, NOx levels were statistically different (p &lt; 0.03) between groups and, as expected, the TC + CC group showed lower values in comparison to the TT group (<xref ref-type="fig" rid="en_aop12210f01-body2">Figure 1-A</xref>). The activity of ecSOD was 30.0% lower in the TC + CC group compared with the TT group, but this difference was not statistically significant (<xref ref-type="fig" rid="en_aop12210f01-body2">Figure 1-B</xref>).</p>
      <p content-type="asset">
        <fig id="en_aop12210f01-body2">
          <graphic xlink:href="1678-4170-abc-95-04-0510-00126-gf01-en.jpg"/></fig>
      </p>
      <p>In the post-training evaluation, the TT group maintained the plasma NOx values of the pre-training, while the TC + CC group had an increase in these levels. After the exercise program (<xref ref-type="fig" rid="en_aop12210f01-body2">Figure 1-A</xref>), no significant difference was found between the groups, ie, the difference found in the pre-training did not remain significant after physical training.</p>
      <p>Both in pre- and in post-exercise program, no differences were observed between groups in the variable blood flow and vascular resistance. Although this result did not reach statistical differences, the TC + CC group showed higher blood flow values compared to the TT group in the pre-training evaluation, suggesting a lower rate of recovery of blood flow (<xref ref-type="fig" rid="en_aop12210f02-body2">Figure 2-A</xref>). In the post-training evaluation, this small difference was not perceived, with both groups presenting about the same result (<xref ref-type="fig" rid="en_aop12210f02-body2">Figure 2-B</xref>). Basically, vascular resistance had the same pattern of blood flow in relation to both groups and evaluations (<xref ref-type="fig" rid="en_aop12210f02-body2">Figure 2-C</xref> and <xref ref-type="fig" rid="en_aop12210f02-body2">2-D</xref>).</p>
      <p content-type="html"><fig id="en_aop12210f02-body2"><graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/NdH7WGqLVzMM6fC6vJ7yMNk/3158a363d5cc60f09880a8c641a5d7e6127471f8.gif"/><graphic xlink:href="1678-4170-abc-95-04-0510-00126-gf02-en.jpg"/></fig>&#13;
</p>
      <p>The Pearson correlation analysis found, in the pre-training evaluation for the TT group, correlations between NOx and BF-0, also found between DBP and the variables of flow and resistance (BF-0, RV-0 and RV-1). In the post-training evaluation, there were correlations between NOx and BF-0 and between the changes in NOx and changes in DBP. For the TC + CC group, no correlation was found in the pre-training evaluation, but in post-training evaluation it was found correlations between DBP and BF-1, BF-2 and BF-3 and between changes in NOx and changes in the BF-1 and DBP. All correlations are summarized in <xref ref-type="table" rid="t2-body2">Table 2</xref>.</p>
      <table-wrap id="t2-body2">
        <graphic xlink:href="1678-4170-abc-95-04-0510-00126-gt02-en.jpg"/></table-wrap>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>This study was conducted to assess the potential effects of T-786C polymorphism of the eNOS gene and six months for a regular program of physical exercise on hemodynamic responses of elderly women pre-hypertensive.</p>
      <p>NO has an important role in vascular control, especially in vasodilation. Both eNOS activity as the mechanisms responsible for the bioavailability of NO contributes to the maintenance of an adequate concentration of nitric oxide in the blood vessel, and both mechanisms may be affected by physical exercise.</p>
      <p>As expected, after 6 months of aerobic exercise, the result of VO<sub>2</sub>max increased significantly for both groups, demonstrating that the intervention applied possessed sufficient stimulus to improve aerobic capacity of participants.</p>
      <p>In blood pressure, both systolic and diastolic, no difference was found between the groups and between pre- and post-training. Several studies have shown a beneficial effect of physical exercise on blood pressure. For example, Hagberg et al<sup>32</sup> found that regular exercise has the ability to reduce BP in approximately 75.0% of hypertensive patients and that training with moderate intensity seems to generate greater benefits than with high intensity, for such reductions. Higashi et al<sup>4</sup> observed a beneficial effect of regular aerobic exercise on blood pressure values for hypertensive patients.</p>
      <p>It is noteworthy, however, that these studies refer to the beneficial effects of physical exercise in hypertensive individuals, unlike the present study, which used pre-hypertensive individuals, a fact that could explain the absence of differences in blood pressure values between pre- and post-physical training.</p>
      <p>The T-786C polymorphism of the eNOS gene is potentially important for cardiovascular control, as has been reported that the presence of C allele decreases the expression of this gene<sup>33</sup>. In the present study, NO metabolites were significantly lower for the TC + CC group compared with the TT group, in the pre-training. This result is in agreement with previous studies, which also showed that individuals carrying the C allele for the same polymorphism had lower concentrations of NO<sup>13,34,35</sup>. For example, Nakayama et al<sup>13</sup> observed that carriers of C allele have a decrease of 50.0% of promoter activity when compared to individuals carrying the T allele, which is consistent with the concept that the C allele may reduce the concentrations of NO.</p>
      <p>In the post-training evaluation, no difference was found for the values of NOx in the TT group. One possible explanation for this finding is that the participants' concentrations of NOx in this group because of the lack of difference between the pre- and post-training, are already at optimal values to maintain BP control. For the TC + CC group, the levels of NOx increased after aerobic training, but this increase was not statistically significant. This result suggests that although physical training has not been enough to increase the concentrations of NOx, an increase of eNOS activity in individuals carrying the C allele, since the difference between the groups in the pre-training evaluation for NOx, did not remain significant in post-training evaluation. This result is in agreement with several other studies that have shown similar results<sup>3,20,36</sup>.</p>
      <p>There is growing evidence to indicate that chronic exercise increases the antioxidant defense system in human blood vessels by increasing the activity of ecSOD<sup>8,14,37</sup>. Aerobic exercise can increase the activity of ecSOD and potentially increase the bioavailability of NO<sup>11,20</sup>. However, the biological activity of NO is dependent on superoxide anions, which compromise the functionality of NO<sup>38</sup>. In this study, the activity of ecSOD was lower for the TC + CC group compared to the TT group in the pre-training evaluation, but this difference did not reach statistical significance.</p>
      <p>After the exercise program, both groups increased the activity of ecSOD proportionally, but this increase remained without statistical differences between evaluatons and groups. Thus, it is suggested that antioxidant activity related to the bioavailability of NO is not impaired in the study participants. This result is in agreement with the study of Di Massimo et al<sup>38</sup> that showed NOx values regardless of the values of ecSOD.</p>
      <p>The release of NO has been considered as a strong mediator for reactive hyperemia in peripheral arteries<sup>4</sup>. Thus, low levels of NOx observed in the TC + CC group, associated with the responses of BF among groups in the pre-training evaluation, are in agreement with other studies that have shown similar results<sup>24</sup>. Although no difference was found in variable BF, the TT group had lower responses in the pre-training evaluation. This result indicates that the TT group returned to resting values more rapidly than TC + CC group.</p>
      <p>Although the individuals carrying the C allele present lower levels of NOx and lower activity of ecSOD in the pre-training evaluation, blood flow still remained relatively high. This result suggests that there are several other substances that may be contributing to this cardiovascular response, eg, potassium, oxygen, carbon dioxide and adenosine<sup>39,40</sup>. From the moment that C allele carriers have some vascular dysfunction, it is possible that other vasodilators are working to control responses to blood flow, thereby offsetting the reduced production of NO<sup>17,40</sup>.</p>
      <p>In TC + CC group, no correlation was found in the pre-training evaluation among variables NOx, BF and BP. This result can be explained by the deleterious effect of C allele in regulating the generation and bioavailability of NO. However, with the correlations found in post-training evaluation among the variables of blood pressure, blood flow and NOx, it can be stated that six months of a regular program of aerobic exercise can increase the relationship between these variables in individuals with C allele.</p>
      <p>After the exercise program, apparently, the TT group had a normal response to vascular function, resulting in a reduced effect of the exercise program at rest and after reactive hyperemia in BF. For the TC + CC group, although blood flow values were higher, the subjects had similar responses compared to the responses from the TT group. So it seems that the ability to return to homeostasis more rapidly in the TC + CC group in post-exercise evaluation, may indicate a favorable response to physical training, resulting in improved peripheral vascular function. This result is in agreement with previous studies that showed a beneficial effect of exercise on blood flow in different genotypes<sup>4,24,36</sup>.</p>
      <p>Although this study has some limitations, such as exclusion of certain population characteristics (obese, diabetic, heart disease patients etc.), the analysis of just a polymorphism and only some substances to the production and to the bioavailability of NO, it is possible to suggest a beneficial effect of physical exercise considering the studies variables.</p>
      <p>In summary, this study found a positive effect of physical exercise program with respect to the T-786C polymorphism of the eNOS gene. This suggests that an increased level of regular physical activity can improve the response to cardiovascular control, especially of NO in C allele carriers, contributing to the relationship between blood pressure and blood flow.</p>
      <p>
        <bold>Acknowledgments</bold>
      </p>
      <p>Department of Kinesiology - University of Maryland / Grant KO1AG019640 (M. D. Brown).</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>This study was funded by Grant KO1AG019640 (M.D. Brown).</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This study is not associated with any post-graduation program.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Art&#237;culos Originales</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="es">Efecto del ejercicio f&#237;sico y del polimorfismo T-786C en la presi&#243;n arterial y en el flujo sangu&#237;neo de a&#241;osas</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: El polimorfismo T-786C del gen de la sintetasa del &#243;xido n&#237;trico endotelial (eNOS) y la producci&#243;n de ani&#243;n super&#243;xido pueden disminuir la producci&#243;n y biodisponibilidad del &#243;xido n&#237;trico, comprometiendo el grado de vasodilataci&#243;n, pudiendo este efecto ser revertido por el ejercicio f&#237;sico. OBJETIVO: Investigar la influencia del entrenamiento aer&#243;bico y del polimorfismo T-786C en las concentraciones de los metabolitos del &#243;xido n&#237;trico (NOx), en el flujo sangu&#237;neo (FS) y en la presi&#243;n arterial (PA). M&#201;TODOS: Treinta y dos a&#241;osas prehipertensas (59 &#177; 6 a&#241;os) fueron separadas en dos grupos de acuerdo con el polimorfismo T-786C (TT y TC+CC). Fueron analizadas las concentraciones de NOx (plasma) y flujo sangu&#237;neo por pletismograf&#237;a de oclusi&#243;n venosa en reposo, 1, 2 y 3 minutos post oclusi&#243;n (FS-0, FS-1, FS-2, FS-3, respectivamente). Las evaluaciones fueron realizadas antes y despu&#233;s de 6 meses de un programa de ejercicio aer&#243;bico. RESULTADOS: En las evaluaciones pre entrenamiento, los niveles de NOx fueron menores en el grupo TC+CC en relaci&#243;n al grupo TT. El grupo TT present&#243; correlaciones entre NOx y FS-0 (r = 0,6) y presi&#243;n arterial diast&#243;lica (PAD) y FS-0 (r = -0,7), sin embargo ninguna correlaci&#243;n fue encontrada en el grupo TC+CC. En las evaluaciones post entrenamiento, ocurrieron correlaciones entre NOx y FS-0 (r = 0,6) y en los cambios del NOx y PAD (r = -0,6) en el grupo TT. Tambi&#233;n fueron obtenidas correlaciones entre PAD y FS-1 (r = -0,8), PAD y FS-2 (r = -0,6), PAD y FS-3 (r = -0,6), en los cambios entre NOx y FS-1 (r = 0,8) y cambios del NOx y PAD (r = -0,7) en el grupo TC+CC. CONCLUSI&#211;N: Se concluye que 6 meses de ejercicio aer&#243;bico pueden contribuir a aumentar las relaciones existentes entre NO, PA y FS en a&#241;osas portadoras del alelo C.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>&#211;xido n&#237;trico</kwd>
        <kwd>super&#243;xido dismutasa</kwd>
        <kwd>ejercicio</kwd>
        <kwd>presi&#243;n arterial</kwd>
        <kwd>a&#241;oso</kwd>
        <kwd>polimorfismo gen&#233;tico</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <fn id="top-body3">
          <label>
            <bold>Efecto del ejercicio f&#237;sico y del polimorfismo T-786C en la presi&#243;n arterial y en el flujo sangu&#237;neo de a&#241;osas</bold>
          </label>
          <p>
            <bold>Anderson Saranz Zago<sup>I</sup>; Eduardo Kokubun<sup>II</sup>; Nicola Fenty-Stewart<sup>III</sup>; Joon-Young Park<sup>III</sup>; Selasi Attipoe<sup>IV</sup>; James Hagberg<sup>IV</sup>; Michael Brown<sup>III</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Escola de Educa&#231;&#227;o F&#237;sica e Esportes - USP, Ribeir&#227;o Preto, SP - Brasil</p>
      <p><sup>II</sup>Departamento de Educa&#231;&#227;o F&#237;sica - UNESP, Rio Claro, SP - Brasil</p>
      <p><sup>III</sup>Department of Kinesiology - Temple University, Philadelphia - USA</p>
      <p><sup>IV</sup>Department of Kinesiology - University of Maryland, College Park - USA</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO:</bold> El polimorfismo T-786C del gen de la sintetasa del &#243;xido n&#237;trico endotelial (eNOS) y la producci&#243;n de ani&#243;n super&#243;xido pueden disminuir la producci&#243;n y biodisponibilidad del &#243;xido n&#237;trico, comprometiendo el grado de vasodilataci&#243;n, pudiendo este efecto ser revertido por el ejercicio f&#237;sico.</p>
      <p><bold>OBJETIVO:</bold> Investigar la influencia del entrenamiento aer&#243;bico y del polimorfismo T-786C en las concentraciones de los metabolitos del &#243;xido n&#237;trico (NOx), en el flujo sangu&#237;neo (FS) y en la presi&#243;n arterial (PA).</p>
      <p><bold>M&#201;TODOS:</bold> Treinta y dos a&#241;osas prehipertensas (59 &#177; 6 a&#241;os) fueron separadas en dos grupos de acuerdo con el polimorfismo T-786C (TT y TC+CC). Fueron analizadas las concentraciones de NOx (plasma) y flujo sangu&#237;neo por pletismograf&#237;a de oclusi&#243;n venosa en reposo, 1, 2 y 3 minutos post oclusi&#243;n (FS-0, FS-1, FS-2, FS-3, respectivamente). Las evaluaciones fueron realizadas antes y despu&#233;s de 6 meses de un programa de ejercicio aer&#243;bico.</p>
      <p><bold>RESULTADOS:</bold> En las evaluaciones pre entrenamiento, los niveles de NOx fueron menores en el grupo TC+CC en relaci&#243;n al grupo TT. El grupo TT present&#243; correlaciones entre NOx y FS-0 (r = 0,6) y presi&#243;n arterial diast&#243;lica (PAD) y FS-0 (r = -0,7), sin embargo ninguna correlaci&#243;n fue encontrada en el grupo TC+CC. En las evaluaciones post entrenamiento, ocurrieron correlaciones entre NOx y FS-0 (r = 0,6) y en los cambios del NOx y PAD (r = -0,6) en el grupo TT. Tambi&#233;n fueron obtenidas correlaciones entre PAD y FS-1 (r = -0,8), PAD y FS-2 (r = -0,6), PAD y FS-3 (r = -0,6), en los cambios entre NOx y FS-1 (r = 0,8) y cambios del NOx y PAD (r = -0,7) en el grupo TC+CC.</p>
      <p><bold>CONCLUSI&#211;N:</bold> Se concluye que 6 meses de ejercicio aer&#243;bico pueden contribuir a aumentar las relaciones existentes entre NO, PA y FS en a&#241;osas portadoras del alelo C.</p>
      <p><bold>Palabras clave:</bold> &#211;xido n&#237;trico, super&#243;xido dismutasa, ejercicio, presi&#243;n arterial, a&#241;oso, polimorfismo gen&#233;tico.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>El &#243;xido n&#237;trico (NO) producido por la sintetasa del &#243;xido n&#237;trico endotelial (eNOS) posee una importante funci&#243;n en el control cardiovascular, especialmente para la vasodilataci&#243;n<sup>1,2</sup>. Cuando la eNOS es activada, el metabolismo de la L-arginina es aumentado generando la formaci&#243;n de L-citrulina y de NO por las c&#233;lulas endoteliales<sup>3-5</sup>. Una vez producido, el NO migra hacia la c&#233;lula muscular lisa vascular generando un aumento de la actividad de la guanilato ciclasa, culminando en la disminuci&#243;n de calcio y en el relajamiento de la musculatura lisa vascular<sup>5,6</sup>.</p>
      <p>En el vaso sangu&#237;neo, entre los mecanismos envueltos en la manutenci&#243;n de las concentraciones adecuadas de NO, se pueden destacar la actividad de la eNOS y la biodisponibilidad de NO<sup>7-12</sup>.</p>
      <p>La actividad de la eNOS puede ser gen&#233;ticamente determinada y algunos polimorfismos han sido identificados como potenciales candidatos para el desarrollo de hipertensi&#243;n arterial<sup>9</sup>. Por ejemplo, el alelo C del polimorfismo T-786C de la regi&#243;n promotora del gen de la eNOS ha sido capaz de disminuir la actividad promotora y transcripcional de ese gen, reduciendo la producci&#243;n de NO<sup>7,13</sup>.</p>
      <p>La biodisponibilidad de NO est&#225; estrechamente relacionada con la producci&#243;n de ani&#243;n super&#243;xido (O<sub>2</sub><sup>-</sup>) producido por el endotelio, capa adventicia y c&#233;lula muscular lisa vascular<sup>1,14-18</sup><sub>.</sub> Tanto factores f&#237;sicos como humorales, como por ejemplo el shear stress, pueden modular la actividad de la NAD(P)H oxidasa e inducir la producci&#243;n de O<sub>2</sub><sup>- 12,19</sup>. El aumento de O<sub>2</sub><sup>-</sup> en el sistema cardiovascular puede generar una disfunci&#243;n endotelial y un aumento de la contractibilidad vascular<sup>2,12</sup>. Cuando es producido en exceso, los O<sub>2</sub><sup>-</sup> reaccionan con el NO produciendo peroxinitrito (ONOO<sup>-</sup>), disminuyendo la biodisponibilidad del NO<sup>2</sup>.</p>
      <p>Contraponi&#233;ndose a los efectos de ambos mecanismos (polimorfismos del gen de la eNOS y de la producci&#243;n de O<sub>2</sub><sup>-</sup>), el ejercicio aer&#243;bico ha sido se&#241;alado como uno de los principales est&#237;mulos para combatir tales disfunciones endoteliales<sup>2,19,20</sup>. El shear stress inducido por el aumento del flujo sangu&#237;neo, especialmente durante la realizaci&#243;n de ejercicios f&#237;sicos, puede beneficiar el mecanismo de control cardiovascular en pr&#225;cticamente dos mecanismos. Primero, por el aumento de la expresi&#243;n de la eNOS y, consecuentemente, de la producci&#243;n de NO, y segundo, por la producci&#243;n de la enzima super&#243;xido dismutasa extracelular (ecSOD), que posee la capacidad de reaccionar con los O<sub>2</sub><sup>-</sup>, aumentando potencialmente la disponibilidad de NO para la c&#233;lula muscular lisa vascular<sup>11,20</sup>.</p>
      <p>De tal forma, el ejercicio f&#237;sico puede regular la vasodilataci&#243;n mediada por el NO disminuyendo los valores de presi&#243;n arterial en la mayor&#237;a de los individuos hipertensos<sup>2</sup>. Con todo, aun existen controversias entre los estudios con relaci&#243;n a los efectos ben&#233;ficos del ejercicio f&#237;sico en el aumento de las concentraciones de NO y en la respuesta vasodilatadora en individuos portadores del polimorfismo del gen de la eNOS<sup>11</sup>.</p>
      <p>As&#237;, el objetivo de este estudio fue investigar la influencia que el ejercicio f&#237;sico regular y el polimorfismo T-786C del gen de la eNOS tendr&#237;an en los niveles circulantes de los metabolitos del NO (NOx), en la actividad de la ecSOD, en el flujo sangu&#237;neo (FS) y en la presi&#243;n arterial (PA) de mujeres a&#241;osas pre-hipertensas.</p>
      <p>
        <bold>Materiales y m&#233;todos</bold>
      </p>
      <p>
        <bold>Participantes</bold>
      </p>
      <p>Este estudio fue aprobado por el Comit&#233; de &#201;tica de la <italic>University of Maryland College Park/USA</italic> y por el Comit&#233; de &#201;tica en Investigaci&#243;n del Instituto de Biociencias/CEP-IB-UNESP.</p>
      <p>En su primera visita al laboratorio, todos los participantes firmaron un t&#233;rmino de consentimiento libre y aclarado. Participaron 32 mujeres aparentemente sanas, entre 50-70 a&#241;os, sedentarias, prehipertensas (sin uso de medicaci&#243;n), no diab&#233;tica y no fumante. Las mujeres con sobrepeso y obesidad (IMC &gt; 37 kg/m<sup>2</sup>) fueron eliminadas del estudio para evitar la interferencia de estas variables en los resultados de este estudio.</p>
      <p>Las participantes fueron divididas en dos grupos seg&#250;n el resultado del an&#225;lisis del polimorfismo del gen de la eNOS, siendo clasificadas como TT y TC+CC. Las mujeres en el per&#237;odo de post-menopausia (83,0% del total de las participantes), que hac&#237;an uso de terapia de reposici&#243;n hormonal (45,0% de las participantes), mantuvieron las medicaciones durante el estudio.</p>
      <p>
        <bold>Procedimientos</bold>
      </p>
      <p>Todos los participantes realizaron el test de Bruce en cinta con electrocardiograma para la detecci&#243;n de enfermedad cardiovascular, seg&#250;n descripto previamente<sup>21</sup>. Un registro de dieta fue realizado y las participantes fueron instruidas a mantener la fase 1 de la dieta del American Heart Association (AHA), con estabilidad del peso por lo menos 3 semanas, seg&#250;n descripto previamente<sup>22</sup>. Todos los tests b&#225;sicos fueron realizados antes y despu&#233;s de 6 meses de un programa de entrenamiento f&#237;sico y la diferencia entre las evaluaciones pre y post (post - pre = diferencia) tambi&#233;n fue utilizada para fines de verificar la eficacia del entrenamiento en cada variable estudiada.</p>
      <p>
        <bold>Tests b&#225;sicos</bold>
      </p>
      <p>Las evaluaciones comprendieron los tests de consumo m&#225;ximo de ox&#237;geno (VO<sub>2</sub>max), flujo sangu&#237;neo (FS), presi&#243;n arterial (PA) y recolecci&#243;n sangu&#237;nea.</p>
      <p><italic>Consumo m&#225;ximo de ox&#237;geno (VO<sub>2</sub>max) -</italic> El VO<sub>2</sub>max fue determinado por el test de agotamiento voluntario, a trav&#233;s de un sistema de calorimetr&#237;a indirecta (modelo 2300, Hans Rudolph, Inc., Kansas City, Missouri) y analizador de gases (modelo 1100, Perkin Elmer, Inc., Danbury, Connecticut) conectados a una computadora. El VO<sub>2</sub>max fue determinado cuando dos de los tres criterios fuesen alcanzados: intercambio respiratorio &gt; 1,1; Frecuencia card&#237;aca &gt; 220 - edad; y un aumento mayor que 150 ml min<sup>"1</sup> en el VO<sub>2,</sub> durante los dos &#250;ltimos minutos de test<sup>23</sup>. Durante el test, la frecuencia card&#237;aca (FC), PA y el electrocardiograma fueron monitoreados.</p>
      <p><italic>Flujo sangu&#237;neo -</italic> Todos los participantes fueron conducidos al laboratorio entre las 7:00 y 9:00 horas despu&#233;s de un ayuno de 12 horas. Los participantes permanecieron en reposo, en la posici&#243;n acostada por 15 minutos, y el flujo sangu&#237;neo fue medido en el antebrazo no dominante usando la t&#233;cnica de pletismograf&#237;a de oclusi&#243;n venosa. Usando un inflador autom&#225;tico, un peque&#241;o manguito fue inflado alrededor de la mu&#241;eca y un manguito mayor alrededor del brazo (h&#250;mero) a 180 mmHg y 55 mmHg, respectivamente. Para criar la isquemia del brazo, el manguito fue inflado a 50 mmHg encima de la presi&#243;n arterial sist&#243;lica de reposo, siendo mantenida por 5 minutos. Despu&#233;s de ese per&#237;odo de isquemia, el manguito de la mu&#241;eca fue inflado nuevamente y el del brazo fue inflado a 55 mmHg, a cada minuto<sup>24</sup>. Ha sido mostrado que el tejido posee la capacidad de recuperarse de la isquemia en tres minutos y que el pico de vasodilataci&#243;n ocurre en aproximadamente un minuto despu&#233;s de la liberaci&#243;n del manguito<sup>24,25</sup>. As&#237;, el FS fue medido en reposo (FS-0) y uno, dos y tres minutos de hiperemia reactiva (FS-1, FS-2 y FS-3, respectivamente), despu&#233;s de los 5 minutos de isquemia. La FC y la PA fueron medidas simult&#225;neamente en el otro brazo. La resistencia vascular (RV) del brazo fue calculada con la media de la PA dividida por el FS.</p>
      <p><italic>Presi&#243;n arterial casual -</italic> Las PA sist&#243;lica y PA diast&#243;lica (PAS y PAD) fueron medidas despu&#233;s de 15 minutos de reposo en la posici&#243;n sentado, en tres d&#237;as separados de acuerdo con el JNC 7 guidelines<sup>26</sup>. La media de las tres medidas fue considerada para fines de an&#225;lisis de datos.</p>
      <p><italic>An&#225;lisis sangu&#237;neo -</italic> Las muestras sangu&#237;neas fueron colectadas en tubos heparinizados para el an&#225;lisis de la actividad de la ecSOD, y en tubos conteniendo EDTA para an&#225;lisis de las concentraciones de los metabolitos del NO (NOx), despu&#233;s de un ayuno de 12 horas, siendo centrifugadas a 2.000 rpm, a 4&#186; C y por 20 minutos. El supernadante plasm&#225;tico fue inmediatamente transferido para eppendorfs y congelado a -80&#186; C para an&#225;lisis posterior.</p>
      <p><italic>Concentraci&#243;n de los metabolitos de NO -</italic> El plasma fue ultrafiltrado y los metabolitos del &#243;xido n&#237;trico (NOx) fueron analizados por ensayo de Greiss (an&#225;lisis de las concentraciones de nitrito despu&#233;s de conversi&#243;n de nitrato para nitrito), seg&#250;n descripto previamente<sup>21,27</sup>. Las muestras fueron analizadas en duplicatas y la media entre ellas fue considerada para fines de an&#225;lisis estad&#237;stico. Los coeficientes de variaci&#243;n intra y inter fueron de 3,3% y 4,9%, respectivamente.</p>
      <p><italic>Actividad de la ecSOD -</italic> La actividad de la ecSOD plasm&#225;tica fue medida a trav&#233;s de kits comerciales de la Cayman Chemicals (Ann Arbor, MI). Las muestras fueron analizadas en duplicado y la media entre ellas fue considerada para fines de an&#225;lisis estad&#237;stico. Los coeficientes de variaci&#243;n intra y inter fueron de 22,0% y 7,0%, respectivamente.</p>
      <p><italic>An&#225;lisis gen&#233;tico -</italic> El ADN de los participantes fue aislado de los leucocitos utilizando el kit de la PureGene (Gentra System, Minneapolis, MN). El polimorfismo T-786C del gen de la eNOS fue detectado a trav&#233;s de reacciones en cadena de polimerasa (PCR), utiliz&#225;ndo los siguientes primers: F:5'-CACCCAGGCCCACCCCAACT-3' and R:5'-GCCGCAGGTCGACAGAGAG ACT-3'. EL ADN fue desnaturalizado por 5 minutos a 95&#186; C, seguido de 35 ciclos de desnaturalizaci&#243;n (30s, 95&#186; C), anillamiento (15s, 54&#186; C) y extensi&#243;n (30s, 72&#186; C). El producto del PCR fue digerido por la enzima MspI a 37&#186; C, seguido de 4 horas en gel de agarosa a 2,0%. El alelo T produjo un fragmento de 415 bp, el alelo C produjo fragmentos de 370 bp y 45 bp.</p>
      <p>Los portadores del alelo C fueron agrupados en un mismo grupo (TC+CC) siendo comparados con el grupo TT. La frecuencia del genotipo TT y TC+CC en la poblaci&#243;n es de aproximadamente 32,0% y 68,0%, respectivamente<sup>28-31</sup>. El alelo C es considerado capaz de generar efectos delet&#233;reos en el sistema cardiovascular y ambos genotipos (TC y CC) demuestran respuestas similares, diferentemente del genotipo TT<sup>13,29</sup>. De esa forma, es apropiado agrupar ambos genotipos TC y CC en un mismo grupo para an&#225;lisis de este estudio.</p>
      <p>
        <bold>Entrenamiento f&#237;sico aer&#243;bico</bold>
      </p>
      <p>Todos los participantes realizaron un programa supervisado de ejercicios f&#237;sicos aer&#243;bico, en cinta ergom&#233;trica, durante 6 meses, tres veces por semana, con intensidad progresiva durante las semanas. Con calentamiento y relajamiento apropiados, la sesi&#243;n inicial consisti&#243; en 20 minutos de ejercicio aer&#243;bico a 50,0% del VO<sub>2</sub>max. La duraci&#243;n del entrenamiento fue aumentada 5 minutos por semana hasta alcanzar 40 minutos. A partir de ese momento, la intensidad era aumentada en 5,0% del VO<sub>2</sub>max cada semana hasta alcanzar 70,0%. El control de la intensidad fue realizado a trav&#233;s de monitores de frecuencia card&#237;aca.</p>
      <p>Apenas los participantes que completaron 75,0% de las sesiones de entrenamiento fueron incluidos en los resultados finales de este estudio.</p>
      <p>
        <bold>An&#225;lisis estad&#237;stico</bold>
      </p>
      <p>Fue realizado un an&#225;lisis descriptivo para ambos grupos (TT y TC+CC) y una ANOVA one-way para detectar diferencias estad&#237;sticas entre los grupos, teniendo en consideraci&#243;n el polimorfismo T-786C del gen de la eNOS como variable independiente y, como variable dependiente, el IMC, la PA, la VO<sub>2</sub>max, la NOx y la actividad de la ecSOD. Una ANOVA two-way fue realizada teniendo como variable independiente el genotipo y el ejercicio f&#237;sico, y, como variable dependiente, el FS, la PA y el IMC. El an&#225;lisis de correlaci&#243;n de Pearson tambi&#233;n fue realizado buscando detectar posibles relaciones entre las variables analizadas en este estudio.</p>
      <p>Todos los resultados fueron expresados en media y error est&#225;ndar de la media. El nivel de significancia fue de p &lt; 0,05. Los datos fueron analizados usando el paquete estad&#237;stico SPSS 13.0.</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>Treinta y dos mujeres pre hipertensas fueron divididos en dos grupos, de acuerdo con el polimorfismo T-786C del gen de la eNOS (TT - 20 participantes y TC+CC - 12 participantes).</p>
      <p>Ninguna diferencia estad&#237;stica fue encontrada entre los grupos en las variables PAS, PAD y IMC, antes y despu&#233;s del programa de ejercicio f&#237;sico. El VO<sub>2</sub>max aument&#243; significativamente en ambos grupos, despu&#233;s del programa de ejercicio f&#237;sico.</p>
      <p>Los valores de IMC, PA y VO<sub>2</sub>max de ambos grupos est&#225;n detallados en la <xref ref-type="table" rid="t1-body3">Tabla 1</xref>.</p>
      <table-wrap id="t1-body3">
        <graphic xlink:href="1678-4170-abc-95-04-0510-00126-gt01-es.jpg"/></table-wrap>
      <p>En la evaluaci&#243;n preentrenamiento, los niveles de NOx fueron estad&#237;sticamente diferentes (p &lt; 0,03) entre los grupos y, como esperado, el grupo TC+CC present&#243; valores m&#225;s bajos con relaci&#243;n al grupo TT (<xref ref-type="fig" rid="es_14f01-body3">Figura 1-A</xref>). La actividad de la ecSOD fue 30,0% menor en el grupo TC+CC con relaci&#243;n al grupo TT, pero esta diferencia no se present&#243; estad&#237;sticamente significante (<xref ref-type="fig" rid="es_14f01-body3">Figura 1-B</xref>).</p>
      <p content-type="asset">
        <fig id="es_14f01-body3">
          <graphic xlink:href="1678-4170-abc-95-04-0510-00126-gf01-es.jpg"/></fig>
      </p>
      <p>En la evaluaci&#243;n post-entrenamiento, el grupo TT mantuvo los valores plasm&#225;ticos de NOx del momento preentrenamiento, mientras que el grupo TC+CC tuvo un aumento en estos niveles. Despu&#233;s del programa de ejercicio f&#237;sico (<xref ref-type="fig" rid="es_14f01-body3">Figura 1-A</xref>), ninguna diferencia significativa fue encontrada entre los grupos, o sea, la diferencia encontrada en la evaluaci&#243;n preentrenamiento no permaneci&#243; significante despu&#233;s del entrenamiento f&#237;sico.</p>
      <p>Tanto en la evaluaci&#243;n pre como en la evaluaci&#243;n post programa de ejercicio f&#237;sico, ninguna diferencia estad&#237;stica fue observada entre los grupos en la variable flujo sangu&#237;neo y en la resistencia vascular perif&#233;rica. Aunque tal resultado no haya alcanzado diferencias estad&#237;sticas, el grupo TC+CC present&#243; valores mayores de flujo sangu&#237;neo comparado al grupo TT en la evaluaci&#243;n preentrenamiento, sugiriendo una menor tasa de recuperaci&#243;n del flujo sangu&#237;neo (<xref ref-type="fig" rid="es_14f02-body3">Figura 2-A</xref>). En la evaluaci&#243;n post entrenamiento, esa peque&#241;a diferencia no fue percibida, presentando ambos grupos pr&#225;cticamente el mismo resultado (<xref ref-type="fig" rid="es_14f02-body3">Figura 2-B</xref>). B&#225;sicamente, la resistencia vascular tuvo el mismo comportamiento del flujo sangu&#237;neo en relaci&#243;n a ambos grupos y evaluaciones (<xref ref-type="fig" rid="es_14f02-body3">Figura 2-C</xref> y <xref ref-type="fig" rid="es_14f02-body3">2-D</xref>).</p>
      <p content-type="html"><fig id="es_14f02-body3"><graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/NdH7WGqLVzMM6fC6vJ7yMNk/f6c8895c54b4850fae8931e94e894251563b7f5e.jpg"/><graphic xlink:href="1678-4170-abc-95-04-0510-00126-gf02-es.jpg"/></fig>&#13;
</p>
      <p>El an&#225;lisis de correlaci&#243;n de Pearson encontr&#243; en la evaluaci&#243;n pre entrenamiento para el grupo TT, correlaciones entre NOx y FS-0, tambi&#233;n encontradas entre PAD y las variables de flujo y resistencia (FS-0, RV-0 y RV-1). En la evaluaci&#243;n post entrenamiento, hubo correlaciones entre NOx y FS-0 y entre los cambios de la NOx y los cambios en la PAD. Para el grupo TC+CC, ninguna correlaci&#243;n significante fue encontrada en la evaluaci&#243;n pre entrenamiento, pero, en la evaluaci&#243;n post-entrenamiento, fueron encontradas correlaciones entre PAD y FS-1, FS-2 y FS-3 y entre los cambios en la NOx y los cambios en el FS-1 y PAD. Todas las correlaciones encontradas est&#225;n resumidas en la <xref ref-type="table" rid="t2-body3">Tabla 2</xref>.</p>
      <table-wrap id="t2-body3">
        <graphic xlink:href="1678-4170-abc-95-04-0510-00126-gt02-es.jpg"/></table-wrap>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>El presente estudio fue desarrollado para evaluar el potencial efecto del polimorfismo T-786C del gen de la eNOS y de 6 meses de un programa regular de ejercicio f&#237;sico en las respuestas hemodin&#225;micas de mujeres a&#241;osas pre-hipertensas.</p>
      <p>El NO posee una importante funci&#243;n en el control vascular, especialmente en la vasodilataci&#243;n. Tanto la actividad de la eNOS como los mecanismos responsables por la biodisponibilidad del NO contribuyen a la manutenci&#243;n de una adecuada concentraci&#243;n de &#243;xido n&#237;trico en el vaso sangu&#237;neo, y ambos mecanismos pueden ser afectados por el ejercicio f&#237;sico.</p>
      <p>Como era esperado, despu&#233;s de 6 meses de ejercicio aer&#243;bico, el resultado del VO<sub>2</sub>max tuvo un aumento significativo para ambos grupos, demostrando que la intervenci&#243;n aplicada posey&#243; est&#237;mulo suficiente para mejorar la capacidad aer&#243;bica de las participantes.</p>
      <p>En la presi&#243;n arterial, tanto sist&#243;lica cuanto diast&#243;lica, ninguna diferencia fue encontrada entre los grupos y entre las evaluaciones pre y post-entrenamiento. Diversos estudios han evidenciado un efecto ben&#233;fico del ejercicio f&#237;sico sobre la presi&#243;n arterial. Por ejemplo, Hagberg et al<sup>32</sup> observaron que el ejercicio f&#237;sico regular posee la capacidad de disminuir la PA en aproximadamente 75,0% de los individuos hipertensos y que el entrenamiento con intensidad moderada parece generar mayores beneficios que los de alta intensidad, para tales reducciones. Higashi et al<sup>4</sup> observaron un efecto ben&#233;fico del ejercicio aer&#243;bico regular en los valores de PA para individuos hipertensos.</p>
      <p>Cabe resaltar, mientras tanto, que esos estudios hacen referencia a los efectos ben&#233;ficos del ejercicio f&#237;sico en individuos hipertensos, diferentemente del presente estudio, que utiliz&#243; individuos pre-hipertensos, hecho que podr&#237;a justificar la ausencia de diferencias en los valores de presi&#243;n arterial entre las evaluaciones pre y post-entrenamiento f&#237;sico.</p>
      <p>El polimorfismo T-786C del gen de la eNOS es potencialmente importante para el control cardiovascular, pues ha sido relatado que la presencia del alelo C disminuye la expresi&#243;n de este gen<sup>33</sup>. En el presente estudio, los metabolitos del NO fueron significativamente menores para el grupo TC+CC comparado con el grupo TT, en la evaluaci&#243;n pre-entrenamiento. Tal resultado est&#225; en concordancia con estudios previos, que tambi&#233;n mostraron que individuos portadores del alelo C para el mismo polimorfismo pose&#237;an menores concentraciones de NO<sup>13,34,35</sup>. Por ejemplo, Nakayama et al<sup>13</sup> observaron que los portadores del alelo C poseen una disminuci&#243;n de 50,0% de la actividad promotora cuando es comparado a los individuos portadores del alelo T, el cual es consistente con el concepto de que el alelo C puede reducir las concentraciones de NO.</p>
      <p>En la evaluaci&#243;n post-entrenamiento, ninguna diferencia fue encontrada para los valores de NOx en el grupo TT. Una posible explicaci&#243;n para ese resultado es que las concentraciones de NOx de los participantes de ese grupo, debido a la ausencia de diferencia entre las evaluaciones pre y post-entrenamiento, ya se encuentran en valores ideales para mantener el control de la PA. Para el grupo TC+CC, los niveles de NOx aumentaron despu&#233;s del entrenamiento aer&#243;bico, pero este aumento no fue estad&#237;sticamente significante. Tal resultado sugiere que, aunque el entrenamiento f&#237;sico realizado no haya sido suficiente para aumentar las concentraciones de NOx, hubo un aumento de la actividad de la eNOS en individuos portadores del alelo C, pues la diferencia existente entre los grupos en la evaluaci&#243;n pre-entrenamiento para la NOx, no se mantuvo significante en la evaluaci&#243;n post-entrenamiento. Ese resultado est&#225; en concordancia con varios otros estudios que mostraron resultados similares<sup>3,20,36</sup>.</p>
      <p>Existen crecientes evidencias para indicar que el ejercicio cr&#243;nico aumenta el sistema de defensa antioxidante en vasos sangu&#237;neos de humanos a trav&#233;s del aumento de la actividad de la ecSOD<sup>8,14,37</sup>. El ejercicio aer&#243;bico puede aumentar la actividad de la ecSOD y potencialmente aumentar la biodisponibilidad de NO<sup>11,20</sup>. Mientras tanto, la actividad biol&#243;gica del NO es dependiente de los aniones super&#243;xidos, los cuales comprometen la funcionalidad del NO<sup>38</sup>. En el presente estudio, la actividad de la ecSOD fue menor para el grupo TC+CC comparado al grupo TT en la evaluaci&#243;n pre-entrenamiento, pero esta diferencia no alcanz&#243; significancia estad&#237;stica.</p>
      <p>Despu&#233;s del programa de ejercicio, ambos grupos aumentaron proporcionalmente la actividad de la ecSOD, pero este aumento permaneci&#243; sin diferencias estad&#237;sticas entre las evaluaciones y grupos. De esa forma, se sugiere que la capacidad antioxidante relacionada a la biodisponibilidad de NO no est&#225; perjudicada en los participantes de este estudio. Ese resultado est&#225; en concordancia con el estudio de Di Massimo et al<sup>38</sup>, que evidenciaron los valores de NOx independientemente de los valores de ecSOD.</p>
      <p>La liberaci&#243;n del NO ha sido considerada como un fuerte mediador para la hiperemia reactiva en arterias perif&#233;ricas<sup>4</sup>. De ese modo, bajos niveles de NOx observados en el grupo TC+CC, asociado a las respuestas del FS entre los grupos en la evaluaci&#243;n pre-entrenamiento, est&#225;n en concordancia con otros estudios que mostraron resultados similares<sup>24</sup>. Aunque ninguna diferencia haya sido encontrada en la variable FS, el grupo TT present&#243; menores respuestas en la evaluaci&#243;n pre-entrenamiento. Tal resultado indica que el grupo TT volvi&#243; a los valores de reposo m&#225;s r&#225;pidamente que el grupo TC+CC.</p>
      <p>A pesar de que los individuos portadores del alelo C presentaron niveles menores de NOx y menor actividad de la ecSOD en la evaluaci&#243;n pre-entrenamiento, el flujo sangu&#237;neo aun permaneci&#243; relativamente elevado. Ese resultado sugiere que existen varias otras sustancias que pueden estar contribuyendo a esta respuesta cardiovascular, como por ejemplo, potasio, ox&#237;geno, di&#243;xido de carbono y adenosina<sup>39,40</sup>. A partir del momento en que los portadores del alelo C poseen alguna disfunci&#243;n vascular, es posible que otros vasodilatadores est&#233;n actuando para controlar las respuestas al flujo sangu&#237;neo, compensando as&#237; la reducida producci&#243;n de NO<sup>17,40</sup>.</p>
      <p>En el grupo TC+CC, ninguna correlaci&#243;n fue encontrada en la evaluaci&#243;n pre-entrenamiento entre las variables NOx, FS y PA. Ese resultado puede ser explicado por el efecto delet&#233;reo del alelo C en la regulaci&#243;n entre producci&#243;n y biodisponibilidad del NO. Mientras tanto, con las correlaciones encontradas en la evaluaci&#243;n post-entrenamiento entre las variables de presi&#243;n arterial, flujo sangu&#237;neo y NOx, se puede afirmar que 6 meses de un programa regular de ejercicios aer&#243;bicos pueden contribuir a aumentar la relaci&#243;n existente entre esas variables en individuos portadores del alelo C.</p>
      <p>Despu&#233;s del programa de ejercicio, aparentemente, el grupo TT pose&#237;a una respuesta normal para la funci&#243;n vascular, resultando en un reducido efecto del programa de ejercicio en reposo y despu&#233;s de la hiperemia reactiva en el FS. Para el grupo TC+CC, aunque los valores de flujo sangu&#237;neo hayan sido m&#225;s altos, los individuos tuvieron respuestas similares comparadas a las respuestas del grupo TT. Siendo as&#237;, parece que la capacidad de retorno a la homeostasis m&#225;s rapidamente, en el grupo TC+CC en la evaluaci&#243;n post-ejercicio, puede indicar una respuesta favorable del entrenamiento f&#237;sico, resultando en una mejora de la funci&#243;n vascular perif&#233;rica. Tal resultado est&#225; en concordancia con estudios previos que mostraron un efecto ben&#233;fico del ejercicio f&#237;sico en el flujo sangu&#237;neo en diferentes genotipos<sup>4,24,36</sup>.</p>
      <p>A pesar de que este estudio posee algunas limitaciones, como por ejemplo, exclusi&#243;n de determinadas caracter&#237;sticas poblacionales (obesos, diab&#233;ticos, cardi&#243;patas etc.), del an&#225;lisis de apenas un polimorfismo y de solamente algunas sustancias relacionadas tanto a la producci&#243;n como a la biodisponibilidad del NO, es posible sugerir un efecto ben&#233;fico del ejercicio f&#237;sico frente a las variables analizadas.</p>
      <p>En resumen, el presente estudio encontr&#243; un efecto positivo del programa de ejercicio f&#237;sico con relaci&#243;n al polimorfismo T-786C del gen de la eNOS. Eso sugiere que un aumento del nivel de actividad f&#237;sica regular puede mejorar la respuesta al control cardiovascular, especialmente del NO en portadores del alelo C, contribuyendo a la relaci&#243;n entre presi&#243;n arterial y flujo sangu&#237;neo.</p>
      <p>
        <bold>Agradecimientos</bold>
      </p>
      <p><italic>Department of Kinesiology - University of Maryland/Grant</italic> KO1AG019640 (M. D. Brown).</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiamiento</bold>
      </p>
      <p>El presente estudio fue financiado por Grant KO1AG019640 (M.D. Brown).</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>No hay vinculaci&#243;n de este estudio a programas de post grado.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
</article>
